<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T19:56:55Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:4441004" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:4441004</identifier><datestamp>2015-05-22</datestamp><setSpec>blackwellopen</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Hum Mutat</journal-id>
      <journal-id journal-id-type="iso-abbrev">Hum. Mutat</journal-id>
      <journal-id journal-id-type="doi">10.1002/(ISSN)1098-1004</journal-id>
      <journal-id journal-id-type="publisher-id">HUMU</journal-id>
      <journal-title-group>
        <journal-title>Human Mutation</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1059-7794</issn>
      <issn pub-type="epub">1098-1004</issn>
      <publisher>
        <publisher-name>John Wiley and Sons Inc.</publisher-name>
        <publisher-loc>Hoboken</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC4441004</article-id>
      <article-id pub-id-type="pmcid">PMC4441004</article-id>
      <article-id pub-id-type="pmc-uid">4441004</article-id>
      <article-id pub-id-type="pmid">25125334</article-id>
      <article-id pub-id-type="doi">10.1002/humu.22633</article-id>
      <article-id pub-id-type="publisher-id">HUMU22633</article-id>
      <article-categories>
        <subj-group subj-group-type="overline">
          <subject>Research Article</subject>
        </subj-group>
        <subj-group subj-group-type="heading">
          <subject>Research Articles</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Functional Characterization and Categorization of Missense Mutations that Cause Methylmalonylâ<styled-content style="fixed-case">C</styled-content>o<styled-content style="fixed-case">A</styled-content> Mutase (<styled-content style="fixed-case">MUT</styled-content>) Deficiency</article-title>
      </title-group>
      <contrib-group>
        <contrib id="humu22633-cr-0001" contrib-type="author">
          <name>
            <surname>Forny</surname>
            <given-names>Patrick</given-names>
          </name>
          <xref ref-type="aff" rid="humu22633-aff-0001">
<sup>1</sup>
</xref>
          <xref ref-type="aff" rid="humu22633-aff-0002">
<sup>2</sup>
</xref>
          <xref ref-type="author-note" rid="humu22633-note-0001">
<sup>â </sup>
</xref>
        </contrib>
        <contrib id="humu22633-cr-0002" contrib-type="author">
          <name>
            <surname>Froese</surname>
            <given-names>D. Sean</given-names>
          </name>
          <xref ref-type="aff" rid="humu22633-aff-0001">
<sup>1</sup>
</xref>
          <xref ref-type="aff" rid="humu22633-aff-0003">
<sup>3</sup>
</xref>
          <xref ref-type="author-note" rid="humu22633-note-0001">
<sup>â </sup>
</xref>
        </contrib>
        <contrib id="humu22633-cr-0003" contrib-type="author">
          <name>
            <surname>Suormala</surname>
            <given-names>Terttu</given-names>
          </name>
          <xref ref-type="aff" rid="humu22633-aff-0001">
<sup>1</sup>
</xref>
        </contrib>
        <contrib id="humu22633-cr-0004" contrib-type="author" corresp="yes">
          <name>
            <surname>Yue</surname>
            <given-names>Wyatt W.</given-names>
          </name>
          <xref ref-type="aff" rid="humu22633-aff-0003">
<sup>3</sup>
</xref>
        </contrib>
        <contrib id="humu22633-cr-0005" contrib-type="author" corresp="yes">
          <name>
            <surname>Baumgartner</surname>
            <given-names>Matthias R.</given-names>
          </name>
          <xref ref-type="aff" rid="humu22633-aff-0001">
<sup>1</sup>
</xref>
          <xref ref-type="aff" rid="humu22633-aff-0002">
<sup>2</sup>
</xref>
        </contrib>
      </contrib-group>
      <aff id="humu22633-aff-0001">
        <label>
          <sup>1</sup>
        </label>
        <named-content content-type="organisation-division">Division for Metabolic Disorders and Children's Research Center</named-content>
        <institution>University Children's Hospital</institution>
        <named-content content-type="city">Zurich</named-content>
        <country country="CH">Switzerland</country>
      </aff>
      <aff id="humu22633-aff-0002">
        <label>
          <sup>2</sup>
        </label>
        <named-content content-type="organisation-division">Zurich Center for Integrative Human Physiology</named-content>
        <institution>University of Zurich</institution>
        <country country="CH">Switzerland</country>
      </aff>
      <aff id="humu22633-aff-0003">
        <label>
          <sup>3</sup>
        </label>
        <named-content content-type="organisation-division">Structural Genomics Consortium</named-content>
        <institution>University of Oxford</institution>
        <country country="GB">UK</country>
      </aff>
      <author-notes>
        <corresp id="correspondenceTo"><label>*</label>Correspondence to: Matthias R. Baumgartner, Division for Metabolic Disorders, University Children's Hospital, Steinwiesstrasse 75, 8032 Zurich, Switzerland. Eâmail: <email>matthias.baumgartner@kispi.uzh.ch</email>; Wyatt W. Yue, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford, UK. E-mail: <email>wyatt.yue@sgc.ox.ac.uk</email></corresp>
        <fn id="humu22633-note-0001">
          <label>â </label>
          <p>These authors contributed equally to this work.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub">
        <day>24</day>
        <month>11</month>
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>12</month>
        <year>2014</year>
      </pub-date>
      <volume>35</volume>
      <issue>12</issue>
      <issue-id pub-id-type="doi">10.1002/humu.2014.35.issue-12</issue-id>
      <fpage>1449</fpage>
      <lpage>1458</lpage>
      <history>
        <date date-type="received">
          <day>06</day>
          <month>6</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>27</day>
          <month>7</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <!--<copyright-statement content-type="issue-copyright"> Copyright &#x000a9; 2014 Wiley Periodicals, Inc. <copyright-statement>-->
        <copyright-statement content-type="article-copyright">Â© 2014 The Authors. <sup>**</sup><italic>Human Mutation</italic> published by Wiley Periodicals, Inc.</copyright-statement>
        <license license-type="creativeCommonsBy">
          <license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <self-uri content-type="pdf" xlink:type="simple" xlink:href="file:HUMU-35-1449.pdf"/>
      <abstract>
        <title>ABSTRACT</title>
        <p>Methylmalonylâ<styled-content style="fixed-case">C</styled-content>o<styled-content style="fixed-case">A</styled-content> mutase (<styled-content style="fixed-case">MUT</styled-content>) is an essential enzyme in propionate catabolism that requires adenosylcobalamin as a cofactor. Almost 250 inherited mutations in the <italic><styled-content style="fixed-case">MUT</styled-content></italic> gene are known to cause the devastating disorder methylmalonic aciduria; however, the mechanism of dysfunction of these mutations, more than half of which are missense changes, has not been thoroughly investigated. Here, we examined 23 patient missense mutations covering a spectrum of exonic/structural regions, clinical phenotypes, and ethnic populations in order to determine their influence on <italic>protein stability</italic>, using two recombinant expression systems and a thermostability assay, and <italic>enzymatic function</italic> by measuring <styled-content style="fixed-case">MUT</styled-content> activity and affinity for its cofactor and substrate. Our data stratify <styled-content style="fixed-case">MUT</styled-content> missense mutations into categories of biochemical defects, including (1) reduced protein level due to misfolding, (2) increased thermolability, (3) impaired enzyme activity, and (4) reduced cofactor response in substrate turnover. We further demonstrate the stabilization of wildâtype and thermolabile mutants by chemical chaperones in vitro and in bacterial cells. This inâdepth mutation study illustrates the tools available for <styled-content style="fixed-case">MUT</styled-content> enzyme characterization, guides future categorization of further missense mutations, and supports the development of alternative, chaperoneâbased therapy for patients not responding to current treatment.</p>
      </abstract>
      <kwd-group kwd-group-type="author-generated">
        <kwd id="humu22633-kwd-0001">methylmalonic aciduria</kwd>
        <kwd id="humu22633-kwd-0002">methylmalonylâCoA mutase</kwd>
        <kwd id="humu22633-kwd-0003">MUT</kwd>
        <kwd id="humu22633-kwd-0004">cobalamin</kwd>
        <kwd id="humu22633-kwd-0005">thermolability</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source>radiz â Rare Disease Initiative Zurich, clinical research priority program, University of Zurich</funding-source>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>Swiss National Science Foundation</funding-source>
          <award-id>SNSF 31003A_138521</award-id>
          <award-id>SNSF 323530_145248</award-id>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>European Molecular Biology Organization (EMBO) ShortâTerm Fellowship</funding-source>
        </award-group>
      </funding-group>
      <counts>
        <page-count count="10"/>
      </counts>
      <custom-meta-group>
        <custom-meta>
          <meta-name>source-schema-version-number</meta-name>
          <meta-value>2.0</meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>component-id</meta-name>
          <meta-value>humu22633</meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>cover-date</meta-name>
          <meta-value>December 2014</meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>details-of-publishers-convertor</meta-name>
          <meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:4.8.6 mode:remove_FC converted:19.04.2016</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
    <notes>
      <fn-group>
        <fn id="humu22633-note-0002">
          <p>Contract grant sponsors: radiz â Rare Disease Initiative Zurich, clinical research priority program, University of Zurich; Swiss National Science Foundation (SNSF 31003A_138521 and SNSF 323530_145248); European Molecular Biology Organization (EMBO) ShortâTerm Fellowship.</p>
        </fn>
        <fn id="humu22633-note-0003">
          <p>Communicated by Elizabeth F. L Neufeld</p>
        </fn>
      </fn-group>
    </notes>
  </front>
  <body>
    <sec id="humu22633-sec-0010">
      <title>Introduction</title>
      <p>Mitochondrial methylmalonylâCoA mutase (MUT, EC 5.4.99.2) catalyzes the reversible isomerisation of <sc>l</sc>âmethylmalonylâCoA to succinylâCoA, requiring vitamin B<sub>12</sub> (cobalamin) in the form of adenosylcobalamin (AdoCbl) as a cofactor. In humans, this reaction represents an important step in propionate catabolism, funneling metabolites from the breakdown of amino acids (valine, isoleucine, methionine, and threonine), oddâchain fatty acids, and the side chain of cholesterol into the tricarboxylic acid cycle. The MUT enzyme is highly conserved from bacteria to human and is well studied at the enzymatic [Fenton etÂ al., <xref rid="humu22633-bib-0013" ref-type="ref">1982</xref>; Banerjee and Ragsdale, <xref rid="humu22633-bib-0004" ref-type="ref">2003</xref>] and structural level [Mancia etÂ al., <xref rid="humu22633-bib-0034" ref-type="ref">1996</xref>; Froese etÂ al., <xref rid="humu22633-bib-0017" ref-type="ref">2010b</xref>]. The importance of the MUTâcatalyzed reaction is further underlined by the metabolic disorder methylmalonic aciduria (MMA), which is caused by a genetic defect in the MUT enzyme itself (MIM# 251000, MMA <italic>mut</italic> type), or in one of several proteins (MMAA, MMAB, MMADHC) involved in the uptake, modification, and delivery of AdoCbl to the MUT enzyme for its activity (MMA <italic>cblA</italic> type, MIM# 251100; MMA <italic>cblB</italic> type, MIM# 251110; MMA <italic>cblDâvariant 2</italic> MIM# 277410) [Fowler etÂ al., <xref rid="humu22633-bib-0014" ref-type="ref">2008</xref>].</p>
      <p>The human <italic>MUT</italic> gene (MIM# 609058; chromosome location 6p12â21.2) [Ledley etÂ al., <xref rid="humu22633-bib-0026" ref-type="ref">1988a</xref>, <xref rid="humu22633-bib-0027" ref-type="ref">b</xref>] is the site of almost 250 deleterious mutations reported to cause MMA [Froese and Gravel, <xref rid="humu22633-bib-0015" ref-type="ref">2010</xref>] (human gene mutation database, HGMD Professional version as of December 2013, hgmd.org). Patient cell lines can be assigned to the <italic>mutâ</italic>type MMA by complementation analysis of fibroblast heterokaryons [Gravel etÂ al., <xref rid="humu22633-bib-0019" ref-type="ref">1975</xref>; Willard etÂ al., <xref rid="humu22633-bib-0052" ref-type="ref">1978</xref>]. Further biochemical characterization, applying MUT activity assay and propionate fixation, allows <italic>mut</italic> classification into two subtypes. Mutants with residual mutase activity in cell homogenates under saturating concentrations of AdoCbl, and whose ability to incorporate [1â<sup>14</sup>C]propionate into acid precipitable material in intact skin fibroblasts is responsive to supplementation of the culture medium with hydroxocobalamin, are designated <italic>mut</italic>
<sup>â</sup>; mutants with no residual MUT activity and no response of propionate incorporation to hydroxocobalamin are designated <italic>mut</italic>
<sup>0</sup> [Willard and Rosenberg, <xref rid="humu22633-bib-0053" ref-type="ref">1980</xref>]. <italic>mut</italic>
<sup>0</sup> patients often present in the newborn period with ketoacidosis, lethargy, repeated vomiting, coma or even death, and suffer from severe longâterm complications such as renal failure and neurological impairments. On the contrary, <italic>mut</italic>
<sup>â</sup> patients have a lower occurrence of mortality, morbidity, and longâterm complications [Horster etÂ al., <xref rid="humu22633-bib-0021" ref-type="ref">2007</xref>]. Dietary interventions, carnitine supplementation, and symptom management are the mainstay of current treatment, although pharmacological doses of hydroxocobalamin are given to some MUTâdeficient patients [Horster etÂ al., <xref rid="humu22633-bib-0021" ref-type="ref">2007</xref>]. Although some <italic>mut</italic>
<sup>â</sup> patients might respond to this treatment, othersâincluding most if not all <italic>mut</italic>
<sup>0</sup> patientsâdo not [Horster etÂ al., <xref rid="humu22633-bib-0021" ref-type="ref">2007</xref>]. Alternative therapeutic approaches should therefore be investigated, evaluating therapeutic potential on the basis of a systematic characterization of individual <italic>mut</italic>
<sup>0</sup> and <italic>mut</italic>
<sup>â</sup> alleles. Nevertheless, the sheer quantity of mutations in the <italic>MUT</italic> geneâmost of which are private and rare [Acquaviva etÂ al., <xref rid="humu22633-bib-0001" ref-type="ref">2005</xref>; Worgan etÂ al., <xref rid="humu22633-bib-0054" ref-type="ref">2006</xref>; Lempp etÂ al., <xref rid="humu22633-bib-0030" ref-type="ref">2007</xref>; Fowler etÂ al., <xref rid="humu22633-bib-0014" ref-type="ref">2008</xref>]âmeans that such a largeâscale analysis has not been forthcoming, with previous reports of in vitro MUT characterization on only a handful of mutations [e.g., Crane and Ledley, <xref rid="humu22633-bib-0011" ref-type="ref">1994</xref>; Janata etÂ al., <xref rid="humu22633-bib-0022" ref-type="ref">1997</xref>].</p>
      <p>Common to many other metabolic disorders (e.g., phenylketonuria (PKU) [Mitchell etÂ al., <xref rid="humu22633-bib-0036" ref-type="ref">2011</xref>]; ornithine transcarbamylase deficiency [Shchelochkov etÂ al., <xref rid="humu22633-bib-0043" ref-type="ref">2009</xref>]), the largest proportion of <italic>MUT</italic> mutations are missense changes (131 of 243, 54%; hgmd.org) whose effects on the protein are difficult to predict a priori [Froese and Gravel, <xref rid="humu22633-bib-0015" ref-type="ref">2010</xref>; Yue etÂ al., <xref rid="humu22633-bib-0055" ref-type="ref">2014</xref>]. MUT is therefore an attractive target to interrogate the genotypeâspecific biochemical penalties for missense mutations at the protein level, an approach adopted for other metabolic enzymes [Pey etÂ al., <xref rid="humu22633-bib-0041" ref-type="ref">2007</xref>; Pekkala etÂ al., <xref rid="humu22633-bib-0040" ref-type="ref">2010</xref>; Shi etÂ al., <xref rid="humu22633-bib-0044" ref-type="ref">2012</xref>]. With this in mind, we have chosen seven <italic>mut</italic>
<sup>0</sup> and 16 <italic>mut</italic>
<sup>â</sup> missense mutations for an inâdepth analysis. On the basis of recombinant expression (<italic>Escherichia coli</italic> and human fibroblasts), thermal denaturation, and enzyme assays, we catalogue each mutation as defective in stability, activity, or both, and further define subcategories in each. To the best of our knowledge, this work represents the first largeâscale biochemical categorization of MUT mutations and sets the stage for exploring the potential of small molecule therapeutics, an approach that is gaining wide interest to augment mutant enzyme activity [Gomes, <xref rid="humu22633-bib-0018" ref-type="ref">2012</xref>].</p>
    </sec>
    <sec id="humu22633-sec-0020">
      <title>Materials and Methods</title>
      <sec id="humu22633-sec-0030">
        <title>Cloning</title>
        <p>For expression in <italic>E. coli</italic>, we used a previously described construct of MUT (called hMUT in [Froese etÂ al., <xref rid="humu22633-bib-0017" ref-type="ref">2010b</xref>]). For expression in fibroblasts, the MUT cDNA sequence was purchased from GeneCopoeia (Rockville, MD, USA) (Construct ID: E0205; RefSeq NM_000255.3) and subsequently subcloned into pTracerâCMV2 (Invitrogen, Carlsbad, CA, USA) via <italic>Eco</italic>RV and <italic>Not</italic>I restriction sites by PCR using the following primers: ACATA<underline underline-style="single">GATATC</underline>CACGCTGTTTTGA (<italic>Eco</italic>RV site underlined) and AGTGGTTGATCGCGTGCATG (<italic>Not</italic>I site is part of the original GeneCopoeia plasmid). All singleâsite missense mutations were generated using the QuikChange siteâdirected mutagenesis kit (Stratagene, La Jolla, CA, USA) following manufacturer's instructions, using forward and reverse primers (Microsynth, Balgach, Switzerland) described in Supp. Table S1, and confirmed by Sanger sequencing.</p>
      </sec>
      <sec id="humu22633-sec-0040">
        <title>Bacterial Expression and Purification</title>
        <p>MUT was expressed in <italic>E. coli</italic> and purified as previously described [Froese etÂ al., <xref rid="humu22633-bib-0017" ref-type="ref">2010b</xref>] with minor modifications. For smallâscale purification, cells were grown in a total of 50 ml, induced with 0.1 mM isopropyl Î²âDâ1âthiogalactopyranoside (IPTG) at 18Â°C overnight, harvested by centrifugation at 4,000<italic>g</italic>, lysed by sonication, and purified by affinity (NiâNTA; Qiagen, Venlo, The Netherlands) chromatography. Where applicable, chemical chaperones were added concurrently with the IPTG. Samples from total cell lysate (1Â Î¼l of 2 ml total) (âLâ), including all cellular proteins both soluble and insoluble, and affinity eluants (15 Î¼l of 250 Î¼l total) (âEâ), including those soluble proteins eluted from the nickel affinity column, were analyzed by SDSâPAGE and stained with Coomassie blue (Expedeon, San Diego, CA, USA). For largeâscale purification, cells were grown in a total of 6Â l, harvested by centrifugation at 5,000<italic>g</italic>, lysed with an Emulsiflex C3 homogenizer, and purified by affinity (NiâNTA, Qiagen), sizeâexclusion (Superdex 200; GE Healthcare, Little Chalfont, UK), cleavage with Hisâtagged TEV protease and reverseâaffinity chromatography (NiâNTA). Purification buffers are detailed in the webpage <ext-link ext-link-type="uri" xlink:href="http://www.thesgc.org/structures/details?pdbid=2XIQ">http://www.thesgc.org/structures/details?pdbid=2XIQ</ext-link>.</p>
      </sec>
      <sec id="humu22633-sec-0050">
        <title>Transfection and Expression in Fibroblasts</title>
        <p>Fibroblasts of a <italic>mut</italic>
<sup>0</sup> patient homozygous for the mutation p.Q30* were immortalized by transfection with pRNS1 [Litzkas etÂ al., <xref rid="humu22633-bib-0031" ref-type="ref">1984</xref>] using electroporation [Baumgartner etÂ al., <xref rid="humu22633-bib-0005" ref-type="ref">2001</xref>] and grown in Dulbecco's Modified Eagle Medium (Gibco, Life Technologies, Zug, Switzerland) supplemented with 10% fetal bovine serum (Gibco) and antibiotics (GE Healthcare), as previously described [Suormala etÂ al., <xref rid="humu22633-bib-0045" ref-type="ref">2004</xref>]. pTracerâMUT wildâtype (<italic>wt</italic>) and mutant constructs were transiently transfected into the immortalized fibroblasts by electroporation with a transfection efficiency of 6%â24%, as determined by fluorescenceâassociated cell sorting measuring the proportion of cells coexpressing the green fluorescent protein from the pTracer construct. This is comparable to previous observations [Coelho etÂ al., <xref rid="humu22633-bib-0009" ref-type="ref">2008</xref>]. Cells were harvested 48 hr after electroporation by trypsinization, washed twice with phosphate buffered saline, and stored frozen at â80Â°C until assayed for MUT activity or used for Western blotting.</p>
      </sec>
      <sec id="humu22633-sec-0060">
        <title>Western Blot</title>
        <p>Fibroblast lysates were obtained by sonication (details under MUT activity assay). Crude cell lysates (25 Î¼g of protein per sample) were mixed with 2Ã Laemmli Sample Buffer (BioâRad, Hercules, CA, USA) and heated to 96Â°C for 6 min. Proteins were separated by 10% SDSâPAGE, transferred to a Protran BA85 nitrocellulose membrane (Whatman, GE Healthcare), blocked at room temperature for 1 hr with buffer A (5% skimmed milk, 1.2% w/v Trisâbase, 9% w/v NaCl, 0.2% Tween 20, pH 7.6), incubated with polyclonal mouse antiâhuman MUT (Abcam, Cambridge, UK) (1:1,000 in buffer A), or Î²âactin (SigmaâAldrich, Buchs SG, Switzerland) (1:4,000 in buffer A) overnight, detected by incubation with goat antiâmouse antibody coupled to horseradish peroxidase (Santa Cruz, Biotechnology, Dallas, TX, USA) (1:5,000 in buffer A) for 1 hr, and visualized with ECL Western Blotting Detection Reagents (GE Healthcare) on a Gel Logic 6000 Pro (Carestream, Gland, Switzerland).</p>
      </sec>
      <sec id="humu22633-sec-0070">
        <title>
<styled-content style="fixed-case">MUT</styled-content> Activity Assay</title>
        <p>MUT activity was assayed in crude cell lysates by measuring the production of [<sup>14</sup>C]succinate from [<sup>14</sup>C]methylmalonylâCoA by a modification of earlier described methods [Baumgartner, <xref rid="humu22633-bib-0006" ref-type="ref">1983</xref>; Causey and Bartlett, <xref rid="humu22633-bib-0008" ref-type="ref">1984</xref>]. All operations were performed in a dark room illuminated with a 15 W red Safelight bulb (Dr. Fischer, Diez/Lahn, Germany). Cell lysates were prepared by pipetting 5 mM potassium phosphate buffer (pH 7.4) on frozen cells and disrupting the pellet by sonicating twice for 15 sec using the microprobe of an XLâ2000 sonicator (Microson, Qsonica, Newtown, CT, USA) at amplitude 1.5. Specific activities were measured in 50Â Î¼l reaction mixture containing 0.1 M potassium phosphate buffer (pH 7.4), 1Â mM DLâ2â[methylâ<sup>14</sup>C]methylmalonylâCoA (American Radiolabeled Chemicals (ARC), St. Louis, MO, USA; specific activity 7.03 MBq/mmol in assay), and 50â100 Î¼g cell proteins without (<italic>holo</italic>âMUT activity) and with (total MUT activity) 50 Î¼M AdoCbl. To estimate <italic>K</italic>
<sub>M</sub> for AdoCbl, its concentration was varied between 0.0025 and 50 Î¼M. To estimate <italic>K</italic>
<sub>M</sub> for methylmalonylâCoA, its concentration was varied between 0.01 and 1.0 mM in the presence of 50 Î¼M AdoCbl. Reactions were initiated by the addition of cell lysate, allowed to proceed for 30 min at 37Â°C, and terminated by addition of 6 Î¼l 5 N KOH (Merck, Whitehouse Station, NJ, USA). Samples were reincubated for 15 min at 37Â°C to hydrolyze CoA derivatives, neutralized by adding 5 Î¼l 5 N perchloric acid (Merck), and spiked with 5 Î¼l of 1% solution (w/v) of succinic acid (Merck) in order to visualize succinate during HPLC separation. Samples were centrifuged to remove precipitate, 50 Î¼l of the supernatant was injected into an Amimex HPXâ87H Ion Exclusion column (300 Ã 7.8 mm<sup>2</sup>; Hâform, 9 Î¼m, BioâRad), and [<sup>14</sup>C]succinate was separated from [<sup>14</sup>C]methylmalonate by elution with 0.5 mM H<sub>2</sub>SO<sub>4</sub> at 30Â°C using a flow rate of 0.4 ml/min. Succinate (retention time 17 min) and methylmalonate (11 min) peaks were visualized at 210 nm using a UV detector; 0.2 ml fractions covering the succinate peak were collected and [<sup>14</sup>C]succinate was quantitated in a TriâCarb C1 900TR scintillation spectrometer (PerkinElmer, Waltham, MA, USA) with Optiphase HiSafe 2 counting cocktail (PerkinElmer). Protein in cell lysates was determined by the Lowry method. MUT activity was expressed as nanomole succinate formed per minute and milligram of protein. <italic>K</italic>
<sub>M</sub> values for AdoCbl were determined using EadieâHofstee plotting.</p>
      </sec>
      <sec id="humu22633-sec-0080">
        <title>Differential Scanning Fluorimetry</title>
        <p>Purified homodimeric MUT was assayed for shifts in melting temperature (<italic>T</italic>
<sub>m</sub>), which is the midpoint transition from a folded to an unfolded state, as previously described [Niesen etÂ al., <xref rid="humu22633-bib-0039" ref-type="ref">2007</xref>; Froese etÂ al., <xref rid="humu22633-bib-0016" ref-type="ref">2010a</xref>]. Each mutant and <italic>wt</italic> protein was assayed in the <italic>apo</italic> state, or with preincubation of 50 Î¼M AdoCbl (SigmaâAldrich), or a combination of 50 Î¼M AdoCbl and 500 Î¼M malonylâCoA (MCoA; SigmaâAldrich). MCoA was used as a substrate analogue because it has been confirmed to bind to the substrate pocket (PDB: 2XIQ) [Froese etÂ al., <xref rid="humu22633-bib-0017" ref-type="ref">2010b</xref>]. For chemical osmolyte screening, various concentrations of proline, betaine, sorbitol, TMAO, sucrose (up to 1,200 mM), and glycerol (up to 20%) were preincubated with protein before analysis.</p>
      </sec>
    </sec>
    <sec id="humu22633-sec-0090">
      <title>Results</title>
      <sec id="humu22633-sec-0100">
        <title>Rationale for Mutation Selection</title>
        <p>From the repertoire of known <italic>MUT</italic> missense mutations, we selected 23 for this study (TableÂ <xref rid="humu22633-tbl-0001" ref-type="table-wrap">1</xref>) with the rationale that they (1) cover both phenotypically severe <italic>mut</italic>
<sup>0</sup> (<italic>n</italic> = 7) and milder <italic>mut</italic>
<sup>â</sup> (<italic>n</italic> = 16) subtypes, (2) are widely distributed across the gene (exons 2â13), and (3) include representative mutations prevalent in different ethnic populations, for example, African Americans (p.G717V and c.2150G&gt;T) [Worgan etÂ al., <xref rid="humu22633-bib-0054" ref-type="ref">2006</xref>], Caucasians (p.N219Y, c.655A&gt;T; p.R369H, c. 1106G&gt;A; p.R694W, c.2080C&gt;T) [Acquaviva etÂ al., <xref rid="humu22633-bib-0001" ref-type="ref">2005</xref>; Lempp etÂ al., <xref rid="humu22633-bib-0030" ref-type="ref">2007</xref>], and Turkish Asians (p.P615T, c.1843C&gt;A) [Dundar etÂ al., <xref rid="humu22633-bib-0012" ref-type="ref">2012</xref>]. These 23 mutations, reported in both homozygous and heterozygous states, are found in highly conserved residues, and their amino acid substitutions are predicted to be largely untolerated according to <italic>SIFT</italic> prediction (TableÂ <xref rid="humu22633-tbl-0001" ref-type="table-wrap">1</xref>B). All selected mutations have been reported (TableÂ <xref rid="humu22633-tbl-0001" ref-type="table-wrap">1</xref>A, references therein) with the exception of p.L736F, c.2206C&gt;T, a novel mutation that exists in a compound heterozygous state with the splice site mutation c.753+2T&gt;A [Worgan etÂ al., <xref rid="humu22633-bib-0054" ref-type="ref">2006</xref>] in an MMA patient diagnosed in our laboratory. Propionate fixation and MUT activity assays on cells from this patient are consistent with the <italic>mut</italic>
<sup>â</sup> subtype.</p>
        <table-wrap id="humu22633-tbl-0001" xml:lang="en" orientation="portrait" position="float">
          <label>Table 1</label>
          <caption>
            <p>Selection of Mutations in the <italic>MUT</italic> Gene and Study Results</p>
          </caption>
          <table frame="hsides" rules="groups">
            <col align="left" span="1"/>
            <col align="left" span="1"/>
            <col align="left" span="1"/>
            <col align="center" span="1"/>
            <col align="left" span="1"/>
            <col align="left" span="1"/>
            <col align="center" span="1"/>
            <col align="center" span="1"/>
            <col align="center" span="1"/>
            <thead>
              <tr>
                <th colspan="5" align="center" style="border-bottom:solid 1px #000000" rowspan="1">Prestudy data</th>
                <th colspan="4" align="center" style="border-bottom:solid 1px #000000" rowspan="1">Study results</th>
              </tr>
              <tr style="border-bottom:solid 1px #000000" valign="bottom">
                <th align="left" valign="bottom" rowspan="1" colspan="1">Predicted amino acid change</th>
                <th align="center" valign="bottom" rowspan="1" colspan="1">Nucleotide change<xref ref-type="fn" rid="humu22633-tbl1-note-0001">a</xref>
</th>
                <th align="center" valign="bottom" rowspan="1" colspan="1">Genomic location</th>
                <th align="center" valign="bottom" rowspan="1" colspan="1">
<italic>mut</italic> subtype</th>
                <th align="center" valign="bottom" rowspan="1" colspan="1">References</th>
                <th align="center" valign="bottom" rowspan="1" colspan="1">Category of biochemical defect</th>
                <th align="center" valign="bottom" rowspan="1" colspan="1">Conservation score<xref ref-type="fn" rid="humu22633-tbl1-note-0002">b</xref>
</th>
                <th align="center" valign="bottom" rowspan="1" colspan="1">Buried surface at dimer (%)<xref ref-type="fn" rid="humu22633-tbl1-note-0003">c</xref>
</th>
                <th align="center" valign="bottom" rowspan="1" colspan="1">SIFT tolerance<xref ref-type="fn" rid="humu22633-tbl1-note-0004">d</xref>
</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" rowspan="1" colspan="1">p.P86L</td>
                <td align="left" rowspan="1" colspan="1">c.257C&gt;T</td>
                <td align="left" rowspan="1" colspan="1">Exon 2</td>
                <td align="center" rowspan="1" colspan="1">
<italic>mut</italic>
<sup>â</sup>
</td>
                <td align="left" rowspan="1" colspan="1">[Worgan etÂ al., <xref rid="humu22633-bib-0054" ref-type="ref">2006</xref>]</td>
                <td align="left" rowspan="1" colspan="1">Thermolabile, <italic>K</italic>
<sub>M</sub>
</td>
                <td align="center" rowspan="1" colspan="1">0.705</td>
                <td align="center" rowspan="1" colspan="1">100</td>
                <td align="center" rowspan="1" colspan="1">0.00</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">p.Y100C</td>
                <td align="left" rowspan="1" colspan="1">c.299A&gt;G</td>
                <td align="left" rowspan="1" colspan="1">Exon 2</td>
                <td align="center" rowspan="1" colspan="1">
<italic>mut</italic>
<sup>â</sup>
</td>
                <td align="left" rowspan="1" colspan="1">[Lempp etÂ al., <xref rid="humu22633-bib-0030" ref-type="ref">2007</xref>]</td>
                <td align="left" rowspan="1" colspan="1">
<italic>K</italic>
<sub>M</sub>
</td>
                <td align="center" rowspan="1" colspan="1">0.953</td>
                <td align="center" rowspan="1" colspan="1">0</td>
                <td align="center" rowspan="1" colspan="1">0.00</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">p.A191E</td>
                <td align="left" rowspan="1" colspan="1">c.572C&gt;A</td>
                <td align="left" rowspan="1" colspan="1">Exon 3</td>
                <td align="center" rowspan="1" colspan="1">
<italic>mut</italic>
<sup>0</sup>
</td>
                <td align="left" rowspan="1" colspan="1">[Acquaviva etÂ al., <xref rid="humu22633-bib-0001" ref-type="ref">2005</xref>; Worgan etÂ al., <xref rid="humu22633-bib-0054" ref-type="ref">2006</xref>]</td>
                <td align="left" rowspan="1" colspan="1">Folding, catalytic</td>
                <td align="center" rowspan="1" colspan="1">0.936</td>
                <td align="center" rowspan="1" colspan="1">0</td>
                <td align="center" rowspan="1" colspan="1">0.00</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">p.Q218H</td>
                <td align="left" rowspan="1" colspan="1">c.654A&gt;C</td>
                <td align="left" rowspan="1" colspan="1">Exon 3</td>
                <td align="center" rowspan="1" colspan="1">
<italic>mut</italic>
<sup>0</sup>
</td>
                <td align="left" rowspan="1" colspan="1">[Worgan etÂ al., <xref rid="humu22633-bib-0054" ref-type="ref">2006</xref>]</td>
                <td align="left" rowspan="1" colspan="1">Catalytic</td>
                <td align="center" rowspan="1" colspan="1">1.000</td>
                <td align="center" rowspan="1" colspan="1">0</td>
                <td align="center" rowspan="1" colspan="1">0.00</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">p.N219Y</td>
                <td align="left" rowspan="1" colspan="1">c.655A&gt;T</td>
                <td align="left" rowspan="1" colspan="1">Exon 3</td>
                <td align="center" rowspan="1" colspan="1">
<italic>mut</italic>
<sup>0</sup>
</td>
                <td align="left" rowspan="1" colspan="1">[Acquaviva etÂ al., <xref rid="humu22633-bib-0001" ref-type="ref">2005</xref>; Worgan etÂ al., <xref rid="humu22633-bib-0054" ref-type="ref">2006</xref>; Lempp etÂ al., <xref rid="humu22633-bib-0030" ref-type="ref">2007</xref>]</td>
                <td align="left" rowspan="1" colspan="1">Catalytic</td>
                <td align="center" rowspan="1" colspan="1">1.000</td>
                <td align="center" rowspan="1" colspan="1">0</td>
                <td align="center" rowspan="1" colspan="1">0.00</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">p.Y231N</td>
                <td align="left" rowspan="1" colspan="1">c.691T&gt;A</td>
                <td align="left" rowspan="1" colspan="1">Exon 3</td>
                <td align="center" rowspan="1" colspan="1">
<italic>mut</italic>
<sup>â</sup>
</td>
                <td align="left" rowspan="1" colspan="1">[Worgan etÂ al., <xref rid="humu22633-bib-0054" ref-type="ref">2006</xref>; Lempp etÂ al., <xref rid="humu22633-bib-0030" ref-type="ref">2007</xref>]</td>
                <td align="left" rowspan="1" colspan="1">
<italic>K</italic>
<sub>M</sub>
</td>
                <td align="center" rowspan="1" colspan="1">0.951</td>
                <td align="center" rowspan="1" colspan="1">0</td>
                <td align="center" rowspan="1" colspan="1">0.00</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">p.Y316C</td>
                <td align="left" rowspan="1" colspan="1">c.947A&gt;G</td>
                <td align="left" rowspan="1" colspan="1">Exon 5</td>
                <td align="center" rowspan="1" colspan="1">
<italic>mut</italic>
<sup>â</sup>
</td>
                <td align="left" rowspan="1" colspan="1">[Worgan etÂ al., <xref rid="humu22633-bib-0054" ref-type="ref">2006</xref>]</td>
                <td align="left" rowspan="1" colspan="1">Unclear</td>
                <td align="center" rowspan="1" colspan="1">0.817</td>
                <td align="center" rowspan="1" colspan="1">97</td>
                <td align="center" rowspan="1" colspan="1">0.00</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">p.L328F</td>
                <td align="left" rowspan="1" colspan="1">c.982C&gt;T</td>
                <td align="left" rowspan="1" colspan="1">Exon 5</td>
                <td align="center" rowspan="1" colspan="1">
<italic>mut</italic>
<sup>0</sup>
</td>
                <td align="left" rowspan="1" colspan="1">[Acquaviva etÂ al., <xref rid="humu22633-bib-0001" ref-type="ref">2005</xref>; Lempp etÂ al., <xref rid="humu22633-bib-0030" ref-type="ref">2007</xref>]</td>
                <td align="left" rowspan="1" colspan="1">Folding, catalytic</td>
                <td align="center" rowspan="1" colspan="1">0.901</td>
                <td align="center" rowspan="1" colspan="1">0</td>
                <td align="center" rowspan="1" colspan="1">0.01</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">p.S344F</td>
                <td align="left" rowspan="1" colspan="1">c.1031C&gt;T</td>
                <td align="left" rowspan="1" colspan="1">Exon 5</td>
                <td align="center" rowspan="1" colspan="1">
<italic>mut</italic>
<sup>â</sup>
</td>
                <td align="left" rowspan="1" colspan="1">[Lempp etÂ al., <xref rid="humu22633-bib-0030" ref-type="ref">2007</xref>]</td>
                <td align="left" rowspan="1" colspan="1">Folding, catalytic</td>
                <td align="center" rowspan="1" colspan="1">0.944</td>
                <td align="center" rowspan="1" colspan="1">0</td>
                <td align="center" rowspan="1" colspan="1">0.00</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">p.N366S</td>
                <td align="left" rowspan="1" colspan="1">c.1097A&gt;G</td>
                <td align="left" rowspan="1" colspan="1">Exon 6</td>
                <td align="center" rowspan="1" colspan="1">
<italic>mut</italic>
<sup>â</sup>
</td>
                <td align="left" rowspan="1" colspan="1">[Lempp etÂ al., <xref rid="humu22633-bib-0030" ref-type="ref">2007</xref>]</td>
                <td align="left" rowspan="1" colspan="1">Catalytic</td>
                <td align="center" rowspan="1" colspan="1">1.000</td>
                <td align="center" rowspan="1" colspan="1">0</td>
                <td align="center" rowspan="1" colspan="1">0.00</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">p.R369H</td>
                <td align="left" rowspan="1" colspan="1">c.1106G&gt;A</td>
                <td align="left" rowspan="1" colspan="1">Exon 6</td>
                <td align="center" rowspan="1" colspan="1">
<italic>mut</italic>
<sup>0</sup>
</td>
                <td align="left" rowspan="1" colspan="1">[Worgan etÂ al., <xref rid="humu22633-bib-0054" ref-type="ref">2006</xref>; Lempp etÂ al., <xref rid="humu22633-bib-0030" ref-type="ref">2007</xref>]</td>
                <td align="left" rowspan="1" colspan="1">Catalytic</td>
                <td align="center" rowspan="1" colspan="1">1.000</td>
                <td align="center" rowspan="1" colspan="1">99</td>
                <td align="center" rowspan="1" colspan="1">0.00</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">p.T387I</td>
                <td align="left" rowspan="1" colspan="1">c.1160C&gt;T</td>
                <td align="left" rowspan="1" colspan="1">Exon 6</td>
                <td align="center" rowspan="1" colspan="1">
<italic>mut</italic>
<sup>â</sup>
</td>
                <td align="left" rowspan="1" colspan="1">[Dundar etÂ al., <xref rid="humu22633-bib-0012" ref-type="ref">2012</xref>]</td>
                <td align="left" rowspan="1" colspan="1">Unclear</td>
                <td align="center" rowspan="1" colspan="1">1.000</td>
                <td align="center" rowspan="1" colspan="1">0</td>
                <td align="center" rowspan="1" colspan="1">0.00</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">p.G426R</td>
                <td align="left" rowspan="1" colspan="1">c.1276G&gt;A</td>
                <td align="left" rowspan="1" colspan="1">Exon 6</td>
                <td align="center" rowspan="1" colspan="1">
<italic>mut</italic>
<sup>â</sup>
</td>
                <td align="left" rowspan="1" colspan="1">[Worgan etÂ al., <xref rid="humu22633-bib-0054" ref-type="ref">2006</xref>]</td>
                <td align="left" rowspan="1" colspan="1">Thermolabile, <italic>K</italic>
<sub>M</sub>
</td>
                <td align="center" rowspan="1" colspan="1">0.702</td>
                <td align="center" rowspan="1" colspan="1">98</td>
                <td align="center" rowspan="1" colspan="1">0.00</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">p.F573S</td>
                <td align="left" rowspan="1" colspan="1">c.1718T&gt;C</td>
                <td align="left" rowspan="1" colspan="1">Exon 10</td>
                <td align="center" rowspan="1" colspan="1">
<italic>mut</italic>
<sup>â</sup>
</td>
                <td align="left" rowspan="1" colspan="1">[Worgan etÂ al., <xref rid="humu22633-bib-0054" ref-type="ref">2006</xref>]</td>
                <td align="left" rowspan="1" colspan="1">Folding</td>
                <td align="center" rowspan="1" colspan="1">0.586</td>
                <td align="center" rowspan="1" colspan="1">0</td>
                <td align="center" rowspan="1" colspan="1">0.03</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">p.P615T</td>
                <td align="left" rowspan="1" colspan="1">c.1843C&gt;A</td>
                <td align="left" rowspan="1" colspan="1">Exon 11</td>
                <td align="center" rowspan="1" colspan="1">
<italic>mut</italic>
<sup>0</sup>
</td>
                <td align="left" rowspan="1" colspan="1">[Acquaviva etÂ al., <xref rid="humu22633-bib-0001" ref-type="ref">2005</xref>; Lempp etÂ al., <xref rid="humu22633-bib-0030" ref-type="ref">2007</xref>]</td>
                <td align="left" rowspan="1" colspan="1">Folding</td>
                <td align="center" rowspan="1" colspan="1">0.862</td>
                <td align="center" rowspan="1" colspan="1">0</td>
                <td align="center" rowspan="1" colspan="1">0.00</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">p.P615L</td>
                <td align="left" rowspan="1" colspan="1">c.1844C&gt;T</td>
                <td align="left" rowspan="1" colspan="1">Exon 11</td>
                <td align="center" rowspan="1" colspan="1">
<italic>mut</italic>
<sup>0</sup>
</td>
                <td align="left" rowspan="1" colspan="1">[Dundar etÂ al., <xref rid="humu22633-bib-0012" ref-type="ref">2012</xref>]</td>
                <td align="left" rowspan="1" colspan="1">Folding</td>
                <td align="center" rowspan="1" colspan="1">0.862</td>
                <td align="center" rowspan="1" colspan="1">0</td>
                <td align="center" rowspan="1" colspan="1">0.00</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">p.V633G</td>
                <td align="left" rowspan="1" colspan="1">c.1898T&gt;G</td>
                <td align="left" rowspan="1" colspan="1">Exon 11</td>
                <td align="center" rowspan="1" colspan="1">
<italic>mut</italic>
<sup>â</sup>
</td>
                <td align="left" rowspan="1" colspan="1">[Worgan etÂ al., <xref rid="humu22633-bib-0054" ref-type="ref">2006</xref>; Lempp etÂ al., <xref rid="humu22633-bib-0030" ref-type="ref">2007</xref>]</td>
                <td align="left" rowspan="1" colspan="1">
<italic>K</italic>
<sub>M</sub>
</td>
                <td align="center" rowspan="1" colspan="1">0.794</td>
                <td align="center" rowspan="1" colspan="1">0</td>
                <td align="center" rowspan="1" colspan="1">0.00</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">p.G648D</td>
                <td align="left" rowspan="1" colspan="1">c.1943G&gt;A</td>
                <td align="left" rowspan="1" colspan="1">Exon 11</td>
                <td align="center" rowspan="1" colspan="1">
<italic>mut</italic>
<sup>â</sup>
</td>
                <td align="left" rowspan="1" colspan="1">[Ledley and Rosenblatt, <xref rid="humu22633-bib-0028" ref-type="ref">1997</xref>]</td>
                <td align="left" rowspan="1" colspan="1">
<italic>K</italic>
<sub>M</sub>
</td>
                <td align="center" rowspan="1" colspan="1">0.729</td>
                <td align="center" rowspan="1" colspan="1">0</td>
                <td align="center" rowspan="1" colspan="1">0.00</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">p.R694W</td>
                <td align="left" rowspan="1" colspan="1">c.2080C&gt;T</td>
                <td align="left" rowspan="1" colspan="1">Exon 12</td>
                <td align="center" rowspan="1" colspan="1">
<italic>mut</italic>
<sup>â</sup>
</td>
                <td align="left" rowspan="1" colspan="1">[Acquaviva etÂ al., <xref rid="humu22633-bib-0001" ref-type="ref">2005</xref>; Lempp etÂ al., <xref rid="humu22633-bib-0030" ref-type="ref">2007</xref>]</td>
                <td align="left" rowspan="1" colspan="1">Catalytic</td>
                <td align="center" rowspan="1" colspan="1">0.549</td>
                <td align="center" rowspan="1" colspan="1">0</td>
                <td align="center" rowspan="1" colspan="1">0.00</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">p.R694L</td>
                <td align="left" rowspan="1" colspan="1">c.2081G&gt;T</td>
                <td align="left" rowspan="1" colspan="1">Exon 12</td>
                <td align="center" rowspan="1" colspan="1">
<italic>mut</italic>
<sup>â</sup>
</td>
                <td align="left" rowspan="1" colspan="1">[Lempp etÂ al., <xref rid="humu22633-bib-0030" ref-type="ref">2007</xref>]</td>
                <td align="left" rowspan="1" colspan="1">Thermolabile, catalytic</td>
                <td align="center" rowspan="1" colspan="1">0.549</td>
                <td align="center" rowspan="1" colspan="1">0</td>
                <td align="center" rowspan="1" colspan="1">0.08</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">p.M700K</td>
                <td align="left" rowspan="1" colspan="1">c.2099T&gt;A</td>
                <td align="left" rowspan="1" colspan="1">Exon 12</td>
                <td align="center" rowspan="1" colspan="1">
<italic>mut</italic>
<sup>â</sup>
</td>
                <td align="left" rowspan="1" colspan="1">[Acquaviva etÂ al., <xref rid="humu22633-bib-0001" ref-type="ref">2005</xref>; Worgan etÂ al., <xref rid="humu22633-bib-0054" ref-type="ref">2006</xref>; Lempp etÂ al., <xref rid="humu22633-bib-0030" ref-type="ref">2007</xref>]</td>
                <td align="left" rowspan="1" colspan="1">Catalytic</td>
                <td align="center" rowspan="1" colspan="1">0.570</td>
                <td align="center" rowspan="1" colspan="1">0</td>
                <td align="center" rowspan="1" colspan="1">0.00</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">p.G717V</td>
                <td align="left" rowspan="1" colspan="1">c.2150G&gt;T</td>
                <td align="left" rowspan="1" colspan="1">Exon 13</td>
                <td align="center" rowspan="1" colspan="1">
<italic>mut</italic>
<sup>â</sup>
</td>
                <td align="left" rowspan="1" colspan="1">[Worgan etÂ al., <xref rid="humu22633-bib-0054" ref-type="ref">2006</xref>]</td>
                <td align="left" rowspan="1" colspan="1">Thermolabile, <italic>K</italic>
<sub>M</sub>
</td>
                <td align="center" rowspan="1" colspan="1">0.840</td>
                <td align="center" rowspan="1" colspan="1">0</td>
                <td align="center" rowspan="1" colspan="1">0.00</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">p.L736F</td>
                <td align="left" rowspan="1" colspan="1">c.2206C&gt;T</td>
                <td align="left" rowspan="1" colspan="1">Exon 13</td>
                <td align="center" rowspan="1" colspan="1">
<italic>mut</italic>
<sup>â</sup>
</td>
                <td align="left" rowspan="1" colspan="1">This study<xref ref-type="fn" rid="humu22633-tbl1-note-0005">e</xref>
</td>
                <td align="left" rowspan="1" colspan="1">Unclear</td>
                <td align="center" rowspan="1" colspan="1">0.625</td>
                <td align="center" rowspan="1" colspan="1">0</td>
                <td align="center" rowspan="1" colspan="1">0.02</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="humu22633-tbl1-note-0001">
              <label>a</label>
              <p>Nucleotide numbering uses +1 as the A of the ATG translation initiation codon in the reference sequence (NM_000255.3), with the initiation codon as codon 1.</p>
            </fn>
            <fn id="humu22633-tbl1-note-0002">
              <label>b</label>
              <p>The conservation score (0 = unconserved; 1 = strictly conserved) was calculated using Scorecons server (<ext-link ext-link-type="uri" xlink:href="http://www.ebi.ac.uk/thornton-srv/databases/cgi-bin/valdar/scorecons_server.pl">http://www.ebi.ac.uk/thorntonâsrv/databases/cgiâbin/valdar/scorecons_server.pl</ext-link>, as of June 2014) [Valdar, <xref rid="humu22633-bib-0048" ref-type="ref">2002</xref>], based on a multiple sequence alignment of 146 MUT homologues from different phyla, generated from the CONSURF server (<ext-link ext-link-type="uri" xlink:href="http://consurf.tau.ac.il/">http://consurf.tau.ac.il/</ext-link>, as of June 2014) [Ashkenazy etÂ al., <xref rid="humu22633-bib-0003" ref-type="ref">2010</xref>].</p>
            </fn>
            <fn id="humu22633-tbl1-note-0003">
              <label>c</label>
              <p>Percentage of the amino acid total surface that is buried in the human MUT dimer, calculated from the PISA server v1.48 (<ext-link ext-link-type="uri" xlink:href="http://www.ebi.ac.uk/pdbe/pisa/">http://www.ebi.ac.uk/pdbe/pisa/</ext-link>) [Krissinel and Henrick, <xref rid="humu22633-bib-0023" ref-type="ref">2007</xref>].</p>
            </fn>
            <fn id="humu22633-tbl1-note-0004">
              <label>d</label>
              <p>SIFT tolerance score (0â0.05 corresponds to amino acid changes that likely affect protein function) was calculated using the SIFT server (<ext-link ext-link-type="uri" xlink:href="http://sift.jcvi.org/">http://sift.jcvi.org/</ext-link>, as of June 2014) [Kumar etÂ al., <xref rid="humu22633-bib-0024" ref-type="ref">2009</xref>].</p>
            </fn>
            <fn id="humu22633-tbl1-note-0005">
              <label>e</label>
              <p>The new variant has been submitted to dbSNP (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/">http://www.ncbi.nlm.nih.gov/SNP/</ext-link>).</p>
            </fn>
          </table-wrap-foot>
          <permissions>
            <copyright-holder>John Wiley &amp; Sons, Ltd.</copyright-holder>
          </permissions>
        </table-wrap>
        <p>We mapped the missense mutations onto the human MUT crystal structure [Froese etÂ al., <xref rid="humu22633-bib-0017" ref-type="ref">2010b</xref>] to understand their local structural environments (Supp. Fig. S1; an interactive version is available at <ext-link ext-link-type="uri" xlink:href="http://www.thesgc.org/MUT">www.thesgc.org/MUT</ext-link>). These mutations are located across the entire polypeptide, including the Nâterminal substrateâbinding domain (<italic>n</italic> = 13), Câterminal cofactorâbinding domain (<italic>n</italic> = 9), and interdomain linker (<italic>n</italic> = 1) (Fig.Â <xref rid="humu22633-fig-0001" ref-type="fig">1</xref>A). A number of them contribute to the binding regions of the substrate (e.g., p.Y100C) and cofactor (e.g., p.M700K) (Fig.Â <xref rid="humu22633-fig-0001" ref-type="fig">1</xref>B), whereas four residues are buried at, or located near, the MUT dimer interface (p.P86L, p.Y316C, p.R369H, p.G426R) (TableÂ <xref rid="humu22633-tbl-0001" ref-type="table-wrap">1</xref>B and Fig.Â <xref rid="humu22633-fig-0001" ref-type="fig">1</xref>B). Compatible with the large proportion of private mutations, no hot spot regions are found for the above, or other known MUT mutations.</p>
        <fig fig-type="Figure" xml:lang="en" id="humu22633-fig-0001" orientation="portrait" position="float">
          <label>Figure 1</label>
          <caption>
            <p>Structural mapping of MUT missense mutations. <bold>A:</bold> The human MUT structure in complex with MCoA and AdoCbl (PDB code 2XIQ) is colored according to domains, that is, Nâterminal substrateâbinding domain cyan, Câterminal cofactorâbinding domain magenta, and interdomain linker yellow. Mutations in this study are shown as red circles (<italic>mut</italic>
<sup>0</sup>) or blue circles (<italic>mut</italic>
<sup>â</sup>). Ligands are in stick representation, colored white for MCoA and black for AdoCbl. <bold>B:</bold> Domain organization of MUT highlighting locations of the studied mutations, dimerization interface, and binding regions for MCoA and AdoCbl in the polypeptide. An interactive version of this structural representation is available online at <ext-link ext-link-type="uri" xlink:href="http://www.thesgc.org/MUT">www.thesgc.org/MUT</ext-link>.</p>
          </caption>
          <graphic id="nlm-graphic-1" xlink:href="HUMU-35-1449-g001"/>
        </fig>
      </sec>
      <sec id="humu22633-sec-0110">
        <title>Effects on Protein Integrity in Two Expression Systems</title>
        <p>The diverse structural locations of the 23 missense mutations, many of which are distant from the catalytic center, suggest some mutations may impact on noncatalytic properties such as the stability of translated polypeptides. To investigate this, we reconstructed these alleles in two recombinant expression systems, <italic>E. coli</italic> and human fibroblasts (Fig.Â <xref rid="humu22633-fig-0002" ref-type="fig">2</xref>A and B), both of which have been used to produce MUT previously [Wilkemeyer etÂ al., <xref rid="humu22633-bib-0051" ref-type="ref">1991</xref>; Janata etÂ al., <xref rid="humu22633-bib-0022" ref-type="ref">1997</xref>; Froese etÂ al., <xref rid="humu22633-bib-0017" ref-type="ref">2010b</xref>]. For <italic>E. coli</italic> expression, the mutant proteins (<italic>n</italic> = 21, excluding p.N219Y and p.Y316C that we were unable to clone) were assessed on their (1) expression level relative to <italic>wt</italic> protein, as judged by protein amount in total cell lysate, and (2) solubility, as judged by protein amount after affinity purification. We first tested several postinduction growth temperatures (37/26/18/12Â°C) for <italic>wt</italic> MUT and observed the highest solubility level with 18Â°C overnight growth (data not shown). Although all 21 mutants are expressed in <italic>E. coli</italic> at this temperature (Fig.Â <xref rid="humu22633-fig-0002" ref-type="fig">2</xref>A, lanes âLâ), a number of them have poor solubility compared with <italic>wt</italic>, resulting in no (p.A191E and p.L328F) or reduced (p.S344F, p.F573S, p.P615T/L) protein recovery from the affinity eluant (lanes âEâ). This observation, unchanged by a lower postinduction temperature (12Â°C; data not shown), indicates insoluble mutant protein expression likely due to a global folding defect. In addition to <italic>E. coli</italic>, we expressed MUT mutants using an immortalized MUTâdeficient patient fibroblast cell line. Western blot (Fig.Â <xref rid="humu22633-fig-0002" ref-type="fig">2</xref>B) of the expressed mutants detected very low protein levels for p.P615T/L, which agrees with bacterial expression. However, the p.A191E and p.L328F proteins, insoluble in <italic>E. coli</italic>, have nearâ<italic>wt</italic> expression levels in human fibroblasts, suggesting that additional factors exclusive to eukaryotes may assist in the proper folding for certain mutant proteins.</p>
        <fig fig-type="Figure" xml:lang="en" id="humu22633-fig-0002" orientation="portrait" position="float">
          <label>Figure 2</label>
          <caption>
            <p>MUT missense mutations confer different effects on stability and activity. <bold>A:</bold> Coomassie staining of SDSâPAGE following smallâscale bacterial expression and affinity purification. For each mutation, lanes for total cell lysate (âL,â left) and eluant after purification (âE,â right) are shown. <bold>B:</bold> Western blot following expression of each mutation in a MUTâdeficient patient cell line. Vector, empty vector. <bold>C:</bold> Total MUT activity (assay with 50 Î¼M AdoCbl) of each mutation expressed as percent of mean <italic>wt</italic> activity. <bold>D:</bold>
<italic>K</italic>
<sub>M</sub> for AdoCbl, expressed as times the mean <italic>wt</italic> value. <bold>E:</bold> â<italic>T</italic>
<sub>m</sub> of <italic>apo</italic> mutant compared to <italic>apoâwt</italic> protein (see Fig.Â <xref rid="humu22633-fig-0003" ref-type="fig">3</xref>). â, not applicable.</p>
          </caption>
          <graphic id="nlm-graphic-3" xlink:href="HUMU-35-1449-g002"/>
        </fig>
      </sec>
      <sec id="humu22633-sec-0120">
        <title>Effects on Enzymatic Function</title>
        <p>MUT catalyzes the isomerization of methylmalonylâCoA to succinylâCoA via reactive radical intermediates generated from a homolytic bond cleavage of AdoCbl [Banerjee and Ragsdale, <xref rid="humu22633-bib-0004" ref-type="ref">2003</xref>]. To investigate if and how each mutation affects MUT enzymatic function, we determined catalytic activity and ligand affinity for <italic>wt</italic> and mutant MUT expressed in MUTâdeficient human fibroblasts. Under saturating AdoCbl levels (50 Î¼M), <italic>wt</italic> MUT exhibited a mean substrate turnover of 20.2 nmol/min/mg protein (Supp. Table S2). All 23 mutants showed decreased enzyme activity, ranging from 0.2% to 85% of <italic>wt</italic> values (Fig.Â <xref rid="humu22633-fig-0002" ref-type="fig">2</xref>C; Supp. Table S2). They can be broadly described as having <italic>high</italic> (&gt;50% of <italic>wt</italic>, <italic>n</italic> = 5), <italic>intermediate</italic> (5%â50% of <italic>wt</italic>, <italic>n</italic> = 6), and <italic>low</italic> (&lt;5% of <italic>wt</italic>, <italic>n</italic> = 12) levels of residual enzyme activity (Supp. Fig. S2). All <italic>mut</italic>
<sup>0</sup> mutants studied were near the assay detection limit (&lt;2% of <italic>wt</italic>), consistent with their reported clinical severity, whereas the <italic>mut</italic>
<sup>â</sup> mutants (2.7%â85% of <italic>wt</italic>) are distributed into all three levels of activity. The more substantial residual activity of <italic>mut<sup>â</sup></italic> mutations allowed us to further determine their <italic>K</italic>
<sub>M</sub> values for AdoCbl and methylmalonylâCoA. <italic>wt</italic> MUT had a mean <italic>K</italic>
<sub>M</sub> for AdoCbl of 4.7 nM (Supp. Table S2), similar to published values [Morrow etÂ al., <xref rid="humu22633-bib-0037" ref-type="ref">1978</xref>]. All characterized mutants exhibited higher <italic>K</italic>
<sub>M</sub> values than <italic>wt</italic>, to varying degrees (Fig.Â <xref rid="humu22633-fig-0002" ref-type="fig">2</xref>D). Seven proteins had a <italic>K</italic>
<sub>M</sub> of &gt;200 times <italic>wt</italic> levels, of which four (p.Y231N, p.G426R, p.G648D, and p.G717V) are at least three orders of magnitude higher, indicating a strong <italic>K</italic>
<sub>M</sub> defect. On the contrary, five proteins had nearâ<italic>wt K</italic>
<sub>M</sub> (e.g., Y316C and p.F573S, &lt;5 times <italic>wt</italic>), suggesting their catalytic impairment is not primarily due to reduced cofactor affinity. No mutants showed large increases in <italic>K</italic>
<sub>M</sub> for methylmalonylâCoA (data not shown), suggesting substrate binding was not defective in these mutants, as has been shown previously [Willard and Rosenberg, <xref rid="humu22633-bib-0053" ref-type="ref">1980</xref>].</p>
      </sec>
      <sec id="humu22633-sec-0130">
        <title>Effects on Protein Thermolability</title>
        <p>To test whether the catalytic impairment of certain MUT mutants relates to changes in their structural integrity, we expressed and purified those mutants in large scale that were sufficiently soluble in <italic>E. coli</italic> (Fig.Â <xref rid="humu22633-fig-0002" ref-type="fig">2</xref>A, <italic>n</italic> = 15). They had similar retention volumes in size exclusion chromatography as <italic>wt</italic> MUT [Froese etÂ al., <xref rid="humu22633-bib-0017" ref-type="ref">2010b</xref>], with no detection of higher order aggregates (data not shown), indicating a nativeâlike homodimer devoid of global folding defects. To identify any subtle stability changes, we applied a differential scanning fluorimetry (DSF) assay [Vedadi etÂ al., <xref rid="humu22633-bib-0049" ref-type="ref">2006</xref>] to follow temperatureâinduced protein unfolding in order to measure the melting temperature (<italic>T</italic>
<sub>m</sub>) of each purified protein. As proof of principle, we first interrogated the stability effect of physiological ligands (cofactor AdoCbl, substrate analogue malonylâCoA) on the <italic>T</italic>
<sub>m</sub> of <italic>wt</italic> MUT, with the rationale that binding of the cognate ligands should stabilize MUT thereby increasing its <italic>T</italic>
<sub>m</sub>. Consistent with this, <italic>wt</italic> MUT (at 1 Î¼M) exhibits a <italic>T</italic>
<sub>m</sub> of 58.2Â°C in the <italic>apo</italic> form, which increases in a doseâdependent manner upon addition of the nativeâlike ligands (Supp. Fig. S3A and B), reaching <italic>T</italic>
<sub>m</sub> values of 60.8Â°C (Î<italic>T</italic>
<sub>m</sub> = 2.6Â°C) with AdoCbl (50 Î¼M), and 73.7Â°C (Î<italic>T</italic>
<sub>m</sub> = 15.5Â°C) with both AdoCbl (50 Î¼M) and MCoA (500 Î¼M) (Fig.Â <xref rid="humu22633-fig-0003" ref-type="fig">3</xref>, inset). The extent of these â<italic>T</italic>
<sub>m</sub> shiftsâ corroborates previous structural observations [Froese etÂ al., <xref rid="humu22633-bib-0017" ref-type="ref">2010b</xref>], in which the smaller Î<italic>T</italic>
<sub>m</sub> by binding AdoCbl alone is consistent with a modest rearrangement in the MUT Câterminal domain (Supp. Fig. S4A), whereas the larger Î<italic>T</italic>
<sub>m</sub> with AdoCbl + MCoA is associated with a substantial conformational change in the Nâterminal domain (Supp. Fig. S4B). Notably, MCoA alone (500 Î¼M) did not increase the <italic>T</italic>
<sub>m</sub> of MUT beyond <italic>apo</italic> levels (data not shown), suggesting an ordered binding mechanism of AdoCbl cofactor first, followed by substrate, in the ternary complex.</p>
        <fig fig-type="Figure" xml:lang="en" id="humu22633-fig-0003" orientation="portrait" position="float">
          <label>Figure 3</label>
          <caption>
            <p>Thermolability of MUT mutations. The change in <italic>T</italic>
<sub>m</sub> values (Î<italic>T</italic>
<sub>m</sub>, compared with <italic>apo wt</italic>) for each mutant MUT in the <italic>apo</italic> state, or following the addition of AdoCbl alone or with AdoCbl and MCoA, is shown. Black, <italic>apo</italic> protein; red, with 50 Î¼M AdoCbl; blue, with 50 Î¼M AdoCbl and 500 Î¼M MCoA. Error bars depict SEM from at least three measurements. (Inset) Representative DSF melting curves of <italic>wt</italic> MUT in the <italic>apo</italic> form (black), with 50 Î¼M AdoCbl (red) and with 50 Î¼M AdoCbl and 500 Î¼M MCoA (blue).</p>
          </caption>
          <graphic id="nlm-graphic-5" xlink:href="HUMU-35-1449-g003"/>
        </fig>
        <p>We subsequently measured the <italic>T</italic>
<sub>m</sub> values of purified mutant proteins in the <italic>apo</italic>, AdoCbl bound, and AdoCbl + MCoA bound states (Fig.Â <xref rid="humu22633-fig-0003" ref-type="fig">3</xref>), to determine if they had a lower <italic>T</italic>
<sub>m</sub> than <italic>wt</italic>, an indicator of protein destabilization [Leandro etÂ al., <xref rid="humu22633-bib-0025" ref-type="ref">2011</xref>]. For clarity, the â<italic>T</italic>
<sub>m</sub> of <italic>apo</italic> mutants compared to <italic>apoâwt</italic> is given in FigureÂ <xref rid="humu22633-fig-0002" ref-type="fig">2</xref>E. Six of 15 proteins exhibited nearâ<italic>wt T</italic>
<sub>m</sub> in their <italic>apo</italic> forms, indicating intact protein integrity. Of these, two (p.F573S, p.V633G) responded to AdoCbl + MCoA stabilization with similar <italic>T</italic>
<sub>m</sub> shifts as <italic>wt</italic>, whereas four (p.Y100C, p.N366S, p.R369H, p.T387I) did not, suggesting that the latter mutants lost the capacity for native ligand stabilization. In particular, p.T387I showed a concentrationâdependent decrease in <italic>T</italic>
<sub>m</sub> when adding AdoCbl alone (Supp. Fig. S3C). The other nine proteins, however, were more thermolabile than <italic>wt</italic> in their <italic>apo</italic> forms. Although five (p.Q218H, p.Y231N, p.G648D, p.R694W, and p.M700K) had slightly lower <italic>T</italic>
<sub>m</sub> than <italic>wt</italic> (Î<italic>T</italic>
<sub>m</sub> range â2.7 to â1.3) and responded to AdoCbl + MCoA stabilization, four (p.P86L, p.G426R, p.R694L, and p.G717V) were substantially more thermolabile than <italic>wt</italic> (maximum destabilization: p.P86L, Î<italic>T</italic>
<sub>m</sub> â8.7Â°C) and did not respond to ligand supplementation.</p>
      </sec>
      <sec id="humu22633-sec-0140">
        <title>Stabilization of <styled-content style="fixed-case">MUT</styled-content> Mutants by Osmolytes</title>
        <p>The insolubility and thermolability of a number of MUT mutants, compared with <italic>wt</italic>, implicate protein destabilization as a biochemical defect and prompted us to investigate the potential for posttranslational stabilization of mutant proteins by six different osmolytes using DSF and bacterial expression (Fig.Â <xref rid="humu22633-fig-0004" ref-type="fig">4</xref>; Supp. Figs. S5 and S6). When applied in high millimolar concentrations, these uncharged, lowâmolecularâweight compounds function as âchemical chaperonesâ and stabilize a number of diseaseâassociated proteins prone to misfolding, an effect likely mediated by osmotic changes in the milieu [Nascimento etÂ al., <xref rid="humu22633-bib-0038" ref-type="ref">2008</xref>; Majtan etÂ al., <xref rid="humu22633-bib-0033" ref-type="ref">2010</xref>]. The two most thermolabile MUT mutants in our study, p.P86L and p.G426R, showed that <italic>T</italic>
<sub>m</sub> increases at high osmolyte concentrations (10% glycerol, 600 mM others), with the efficacy of stabilization dependent on the osmolyte used (Fig.Â <xref rid="humu22633-fig-0004" ref-type="fig">4</xref>A and B). These osmolytes confer a nonsaturating dose response, and the effect appears nonselective, as <italic>wt</italic> and all mutant proteins tested demonstrate stabilization in their <italic>apo</italic> forms to similar degrees (Supp. Fig. S5). To determine if osmolytes could also stabilize proteins cotranslationally, we expressed several mutants with varying levels of solubility in <italic>E. coli</italic> and supplemented their growth (Supp. Fig. S6). Compared with no supplement control, soluble protein yield was improved with glycerol (at 1% concentration: p.A191E and p.G426R; 5%: p.R694W), TMAO (100 mM: p.P615T and p.R694W), and to a lesser extent betaine (100 mM: p.R694W). No improvement for p.L328F was seen, whereas <italic>wt</italic> protein was very soluble under all conditions, suggesting the rescue could be mutant specific. Together, our data demonstrate the amenability of small exogenous molecules to modulate MUT stability, and support the notion to develop targetâspecific âpharmacological chaperonesâ (PCs).</p>
        <fig fig-type="Figure" xml:lang="en" id="humu22633-fig-0004" orientation="portrait" position="float">
          <label>Figure 4</label>
          <caption>
            <p>Stabilization of mutant MUT by osmolytes. Representative DSF melting curves for p.P86L (<bold>A</bold>) and p.G426R (<bold>B</bold>) mutants in the <italic>apo</italic> form (gray) and in the presence of osmolytes (colors) are shown along with <italic>wt</italic> MUT (black).</p>
          </caption>
          <graphic id="nlm-graphic-7" xlink:href="HUMU-35-1449-g004"/>
        </fig>
      </sec>
    </sec>
    <sec id="humu22633-sec-0150">
      <title>Discussion</title>
      <p>Our study aimed to establish a genotypeâphenotype correlation by characterizing the biochemistry associated with a set of <italic>MUT</italic> missense mutations. Earlier smallâscale studies have tested the activity and expression of MUT missense mutants, for example, using the lower eukaryote <italic>Saccharomyces cerevisiae</italic> (five mutations) (Crane and Ledley, <xref rid="humu22633-bib-0011" ref-type="ref">1994</xref>) and <italic>E. coli</italic> (four mutations) [Janata etÂ al., <xref rid="humu22633-bib-0022" ref-type="ref">1997</xref>] as recombinant hosts. Our selected set of 23 mutants, five of which overlap with those previous studies (p.Y231N, p.R369H, p.G648D, p.R694W, p.G717V), constitutes to our knowledge the largest biochemical analysis of MUT mutations to date.</p>
      <sec id="humu22633-sec-0160">
        <title>A Catalogue of Biochemical Defects in <styled-content style="fixed-case">MUT</styled-content> Mutants</title>
        <p>Traditionally, MMA phenotypes are broadly classified into <italic>mut</italic>
<sup>0</sup> and <italic>mut</italic>
<sup>â</sup> subtypes based on the response of a patient cell line to hydroxocobalamin in propionate incorporation [Lempp etÂ al., <xref rid="humu22633-bib-0030" ref-type="ref">2007</xref>]. In order to understand the molecular mechanism(s) governing the <italic>mut</italic>
<sup>0</sup>/<italic>mut</italic>
<sup>â</sup> subtypes and catalogue the associated biochemical defects, we have further assessed MUT mutations based on stability and catalytic properties as summarized in TableÂ <xref rid="humu22633-tbl-0001" ref-type="table-wrap">1</xref>B.</p>
        <p>We evaluated mutants on two stability criteria, <italic>folding</italic> and <italic>thermolability</italic>. <italic>Folding</italic> defects refer to the aggregation or degradation of translated polypeptides, thereby reducing the steadyâstate protein. These mutants displayed drastically reduced soluble protein yield, as exemplified by p.P615T/L. Four other mutants, two from each <italic>mut</italic> subtype (<italic>mut</italic>
<sup>0</sup>: p.A191E, p.L328F; <italic>mut</italic>
<sup>â</sup>: p.S344F, p.F573S), also fit this category having reduced detectable protein in one of the two expression systems. A few mutants displayed only slightly decreased soluble <italic>E. coli</italic> expression, such as p.G717V and p.R694W, consistent with a previous report [Crane and Ledley, <xref rid="humu22633-bib-0011" ref-type="ref">1994</xref>] and were not included in the <italic>folding</italic> category. <italic>Thermolabile</italic> mutants had nearâ<italic>wt</italic> levels of recombinant expression and solubility, reflecting nearânative folding, but increased temperature sensitivity. Four mutations in this study fell into the <italic>thermolabile</italic> category (p.P86L, p.G426R, p.R694L, p.G717V).</p>
        <p>Inspection of the MUT crystal structure shows that both <italic>folding</italic> and <italic>thermolabile</italic> mutants involve amino acid changes that (1) remove a conformationally restricted proline residue (e.g., p.P86L and p.P615L/T), (2) cause steric clashes with a bulky side chain (e.g., p.L328F and p.S344F), or (3) disrupt the natively charged/polar (e.g., p.R694L) or nonpolar (e.g., p.A191E) environment. Furthermore, stability mutations are distributed across the entire polypeptide, indicating that all domains of the protein contribute to its intrinsic stability.</p>
        <p>In addition to stability mutants, we also identified direct kinetic impairment, which we termed <italic>catalytic</italic> and <italic>K</italic>
<sub>M</sub> mutants. <italic>Catalytic</italic> mutants had low residual activity (&lt;5% of <italic>wt</italic>) despite detectable eukaryotic expression and constituted the largest category of mutants (10 in this study, TableÂ <xref rid="humu22633-tbl-0001" ref-type="table-wrap">1</xref>B). Of particular note, two <italic>catalytic</italic> mutants, p.Q218H and p.A219E, involve structurally adjacent residues lining the substrateâbinding channel (Fig.Â <xref rid="humu22633-fig-0001" ref-type="fig">1</xref>A; Supp. Fig. S1D and E), where p.Q218 has been implicated in transition state stabilization [Loferer etÂ al., <xref rid="humu22633-bib-0032" ref-type="ref">2003</xref>]. <italic>K</italic>
<sub>M</sub> mutants exhibited &gt;200âfold increased <italic>K</italic>
<sub>M</sub> for AdoCbl compared with <italic>wt</italic>. Among the seven <italic>K</italic>
<sub>M</sub> mutants identified (TableÂ <xref rid="humu22633-tbl-0001" ref-type="table-wrap">1</xref>B), only three (p.V633G, p.G648D, and p.G717V) are buried within the Câterminal cobalaminâbinding domain (Fig.Â <xref rid="humu22633-fig-0001" ref-type="fig">1</xref>A; Supp. Fig. S1P, Q, and T). The other four are toward the Nâterminal end: p.Y231N is situated at the interdomain interface, within a loop that contacts the cobalamin corrin ring (Supp. Fig. S1F); p.G426R is situated at the dimeric interface; and p.P86L and p.Y100C are located near the Nâterminal substrateâbinding channel, distant from any obvious involvement in cobalamin binding. Further investigation is therefore warranted to understand how the <italic>K</italic>
<sub>M</sub> effect of these mutations is mediated.</p>
        <p>It is of note that our classification scheme is not aimed at <italic>pigeonholing</italic> mutant alleles into disparate, mutually exclusive categories; on the contrary, there is a high degree of interdependence between various stability and catalytic properties that together contribute to proper enzyme function. This is clearly exemplified with seven mutants fitting multiple criteria. Three of them had a significantly increased <italic>K</italic>
<sub>M</sub> but were also thermolabile (p.P86L, p.G426R, and p.G717V), one was <italic>thermolabile</italic> with a <italic>catalytic</italic> dysfunction (p.R694L), and three met the criteria of <italic>folding</italic> and <italic>catalytic</italic> defects (p.A191E, p.L328F, p.S344F). In addition, three mutations were termed <italic>unclear</italic> (p.Y316C, p.T387I, and p.L736F) because in our assays they lack definitive aberration in stability and enzyme kinetics, showed detectable protein by Western blot, intermediate enzyme activity, and only moderate <italic>K</italic>
<sub>M</sub> change.</p>
        <p>Future studies should aim to address the lesser characterized biochemical aspects of MUT and possible mutational effects, which are beyond the scope of this study. These include (1) possible allostery between substrate and cofactor binding, which could potentially explain the <italic>T</italic>
<sub>m</sub> shift from MCoA + AdoCbl but not MCoA alone; (2) potential formation of a supramolecular complex with the GTPase MMAA and adenosyltransferase MMAB [Froese and Gravel, <xref rid="humu22633-bib-0015" ref-type="ref">2010</xref>], required for the proper assembly of AdoCbl onto the MUT enzyme; and (3) interallelic rescue of certain MUT disease alleles (e.g., p.R93H and p.G717V) [Worgan etÂ al., <xref rid="humu22633-bib-0054" ref-type="ref">2006</xref>].</p>
      </sec>
      <sec id="humu22633-sec-0170">
        <title>Clinical Utility and Implications of In Vitro Characterization</title>
        <p>A clinical application for our biochemical categorization of <italic>MUT</italic> genotypes is to help prognosticate the course of the disease. As expected, the characterized <italic>mut</italic>
<sup>0</sup> mutants harbor <italic>folding</italic> or <italic>catalytic</italic> defects, resulting in very low or undetectable residual enzyme activities consistent with their predominance in neonatal onset patients with severe longâterm complications. On the contrary, the characterized <italic>mut</italic>
<sup>â</sup> mutants can present in any one, or combinations, of the four biochemical defects defined here. We postulate that mutations that do not interfere with protein stability and have less of a catalytic penalty would result in milder disease (e.g., p.P86L or p.G426R). Similar to other metabolic diseases where an activity threshold of â¼5%â10% of <italic>wt</italic> is sufficient to ameliorate disease [Leinekugel etÂ al., <xref rid="humu22633-bib-0029" ref-type="ref">1992</xref>; Suzuki, <xref rid="humu22633-bib-0046" ref-type="ref">2013</xref>], <italic>mut</italic>
<sup>â</sup> patients often show a later onset and less longâterm complications, presumably due to the intermediate level of residual MUT activity.</p>
        <p>Whether any MUTâdeficient patient, including those of the <italic>mut<sup>â</sup></italic> subtype, benefit from treatment with high doses of hydroxocobalamin is controversial. Early publications documented no response [Wilcken etÂ al., <xref rid="humu22633-bib-0050" ref-type="ref">1977</xref>; Matsui etÂ al., <xref rid="humu22633-bib-0035" ref-type="ref">1983</xref>] and a recent documentation of a possible response has relied on retrospective reviews [Horster etÂ al., <xref rid="humu22633-bib-0021" ref-type="ref">2007</xref>], whereas up to now, no controlled studies clearly demonstrating response to hydroxocobalamin have been published. This picture is very different from PKU, where &gt;40% patients respond clinically to the cognate cofactor tetrahydropterin (BH<sub>4</sub>) of phenylalanine hydroxylase (PAH) [Zurfluh etÂ al., <xref rid="humu22633-bib-0056" ref-type="ref">2008</xref>]. For <italic>mutâ</italic>type MMA, a clinical response to treatment is usually defined as reduced plasma or urinary concentration of methylmalonic acid. Although difficult to measure because of its broad variation in body fluids [Thompson and Chalmers, <xref rid="humu22633-bib-0047" ref-type="ref">1990</xref>; Horster etÂ al., <xref rid="humu22633-bib-0021" ref-type="ref">2007</xref>; Fowler etÂ al., <xref rid="humu22633-bib-0014" ref-type="ref">2008</xref>], and clinical improvement even more difficult to determine reliably, lower methylmalonic acid levels are thought to reflect a higher residual enzyme activity protecting patients from severe longâterm complications (e.g., chronic renal failure and neurological complications) [Thompson and Chalmers, <xref rid="humu22633-bib-0047" ref-type="ref">1990</xref>; Horster etÂ al., <xref rid="humu22633-bib-0021" ref-type="ref">2007</xref>; Cosson etÂ al., <xref rid="humu22633-bib-0010" ref-type="ref">2009</xref>]. Therefore, careful evaluation of potential responsiveness to hydroxocobalamin treatment in all MMA patients is warranted, and a protocol has been proposed [Fowler etÂ al., <xref rid="humu22633-bib-0014" ref-type="ref">2008</xref>]. Our thermal denaturation data offer a molecular explanation to a possible mechanism of cobalamin treatment by revealing AdoCblâinduced stability improvement in certain mutants in a ligandâspecific manner similar to that of BH<sub>4</sub> on mutant PAH. Our results also predict that patients harboring a <italic>K</italic>
<sub>M</sub> defect (e.g., p.G648D) are more likely to benefit from cobalamin treatment based on the assumption that increased hydroxocobalamin plasma levels result in increased cellular AdoCbl production because, in our enzyme assay, these mutants exhibited high activity levels in the presence of high AdoCbl concentration. Nevertheless, hydroxocobalamin treatment may only benefit a small subset of patients with intermediate to high residual activity, if any, outlining an imperative to search for alternative therapies.</p>
      </sec>
      <sec id="humu22633-sec-0180">
        <title>Small Molecule Chaperones as Alternative Therapy?</title>
        <p>Our stability data add MUT to the growing list of metabolic enzymes in which mutationâinduced protein destabilization is widely believed to play a causative role in disease pathogenesis [Gregersen etÂ al., <xref rid="humu22633-bib-0020" ref-type="ref">2006</xref>]. In this model, mutant polypeptides tend to misfold, aggregate, and be degraded by protein quality control in the cell. Chemical or pharmacologic approaches to partially correct misfolding, divert the mutant polypeptide from degradation/aggregation pathways, and deliver it to the native subcellular destination may therefore allow a sufficient recovery of physiological function. This small molecule âchaperoningâ approach has been proposed as a viable treatment for a number of protein misfolding diseases [Pey etÂ al., <xref rid="humu22633-bib-0042" ref-type="ref">2008</xref>; Gomes, <xref rid="humu22633-bib-0018" ref-type="ref">2012</xref>]. We provide proof of principle for MUT chaperone therapy by showing in vitro and in cell stabilization of several mutant proteins using chemical osmolytes. These small organic solutes enhance protein stability via a nonselective, nontargetâspecific mode of preferential exclusion from the protein's surface [Arakawa and Timasheff, <xref rid="humu22633-bib-0002" ref-type="ref">1985</xref>], although necessitating high effective concentrations (in millimolar range) that may be toxic to the cellârestricting their therapeutic utility.</p>
        <p>Alternatively, targetâspecific PCs could be developed for MUT that, unlike chemical chaperones, exert a direct stabilization effect by binding to the affected protein, potentially allowing lower, clinically tolerable dosage concentrations. PCs have shown promise in several lysosomal storage diseases, entering earlyâstage clinical trials for Gaucher, TayâSachs, and Fabry diseases [Boyd etÂ al., <xref rid="humu22633-bib-0007" ref-type="ref">2013</xref>]. In the case of MUT, we anticipate that an effective PC molecule need only to stabilize the mutant protein âlong enoughâ to be delivered to mitochondria, where it can be further stabilized by its native ligands and protein interaction partners (MMAA and MMAB). Such a PC molecule may increase the residual enzyme activity of the mutant protein to a sufficient level that copes with the cellular demands of propionate catabolism. Therefore, PC therapy is likely to rescue mild stability defects (i.e., alleles that give rise to destabilized protein and partial loss of function; e.g., p.G426R, p.M700K, and p.G717V), either to be administered alone or as a complement to the existing diet/hydroxocobalamin treatment. Other <italic>catalytic</italic>, <italic>K</italic>
<sub>M</sub> mutations, without stability defects, may also benefit from PCs that potentially increase residual activity, acting as âenzymatic activators.â Altogether, the stage is set for a systematic, nonbiased screening regime in the search for PC molecules targeting MUT, and our established DSF assay may provide a good starting point for this screening.</p>
      </sec>
    </sec>
    <sec sec-type="supplementary-material">
      <title>Supporting information</title>
      <supplementary-material content-type="local-data">
        <p>Disclaimer: Supplementary materials have been peerâreviewed but not copyedited.</p>
      </supplementary-material>
      <supplementary-material content-type="local-data">
        <caption>
          <p>
<bold>Figure S1</bold>. Structural view of the amino acid environment for each mutation in this study. For each panel, the amino acid of interest is coloured cyan. Secondary structure elements are coloured cyan for the Nâterminal substrate binding domain, yellow for interâdomain linker, and magenta for Câterminal cobalamin binding domain. For panels <bold>a, b, d, e, i</bold> and <bold>l</bold>, malonylâCoA is shown as sticks (yellow carbon atoms). For panels <bold>d, k, p, q, s</bold> and <bold>t</bold>, adenosylcobalamin is shown as sticks (black carbon atoms). For panels <bold>a, g, k</bold> and <bold>m</bold>, the neighboring subunit in the MUT dimer is shown as black cartoon. For panels <bold>c, h, m, o</bold> and <bold>q</bold>, amino acids surrounding the site of interest are also shown in spheres, to highlight the tight steric packing. Where applicable, hydrogen bonds are shown as dashed lines (distance in angstrom). An interactive verâsion of this structural representation is available at <ext-link ext-link-type="uri" xlink:href="http://www.thesgc.org/MUT">www.thesgc.org/MUT</ext-link>.</p>
          <p>
<bold>Figure S2</bold>. Enzyme activities of MUT <italic>wt</italic> and mutants in decreasing order. Each bar represents the mean of at least two replicate experiments (error bars depict SEM). Black bars indicate <italic>high</italic> (50â100% of <italic>wt</italic>, n=5), dotted bars <italic>intermediate</italic> (6â49% of <italic>wt</italic>, <italic>n</italic>=5) and white bars <italic>low</italic> (0â5% of <italic>wt</italic>, <italic>n</italic>=13) levels of acâtivity</p>
          <p>
<bold>Figure S3</bold>. Ligandâdependent thermal denaturation of MUT. <italic>wt</italic> MUT is stabilized with increasing concentrations of AdoCbl (<bold>A</bold>) and malonylâCoA (<bold>B</bold>). Mutant p.T387I is destabilized with increasing AdoCbl concentrations (<bold>C</bold>).</p>
          <p>
<bold>Figure S4</bold>. Substrate/cofactorâinduced conformational changes in MUT. <bold>A</bold>. Superposition of MUT structures in the <italic>apo</italic> and AdoCblâbound (<italic>holo</italic>) states shows modest rearrangement in the Câterminal domain (boxed) by the binding of AdoCbl alone. <bold>B</bold>. Superposition of MUT structures in the <italic>holo</italic> and ternary (AdoCbl and MCoA bound) states reveals substantial conformational changes in the Nâterminal domain (boxed) by the additional binding of MCoA. Ligands are shown in sticks (AdoCbl, yellow carbon; MCoA, green carbon. (PDB codes: <italic>apo</italic>, 2XIQ; <italic>holo</italic>, 2XIJ; ternary, 2XIQ).</p>
          <p>
<bold>Figure S5</bold>. Concentrationsâdependent thermal stabilization in wildâtype and mutant MUT upon addition of chemical chaperones: <bold>A</bold>. proline, <bold>B</bold>. glycerol, <bold>C</bold>. betaine, <bold>D</bold>. sorbitol, <bold>E</bold>. TMAO, <bold>F</bold>. sucrose.</p>
          <p>
<bold>Figure S6</bold>. SDSâPAGE of test purification for wildâtype, p.A191E, p.L328F, p.G426R, p.P615T and p.R694W after coâtranslational expression in the presence of chemical osmolytes. Glycerol (at 1% and 5%), TMAO and betaine at 100 mM were tested. For clarity, only the relevant gel section is shown. CC: chemical chaperone; TLC: total cell lysate; E: eluant after affinity purification; marker on left: sizes in kDa.</p>
          <p>
<bold>Table S1</bold>. Primers used for siteâdirected mutagenesis of pTracerâMUT <italic>wt</italic> and pNICâMUT <italic>wt</italic> constructs</p>
          <p>
<bold>Table S2</bold>. MethylmalonylâCoA mutase (MUT) activities and KM values for the cofactor, adeânosylcobalamin (AdoCbl)</p>
        </caption>
        <media xlink:href="HUMU-35-1449-s001.pdf">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <ack id="humu22633-sec-0190">
      <title>Acknowledgments</title>
      <p>The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from AbbVie, Boehringer Ingelheim, the Canada Foundation for Innovation, the Canadian Institutes for Health Research, Genome Canada, GlaxoSmithKline, Janssen, Lilly Canada, the Novartis Research Foundation, the Ontario Ministry of Economic Development and Innovation, Pfizer, Takeda, and the Wellcome Trust [092809/Z/10/Z].</p>
    </ack>
    <ref-list id="humu22633-bibl-0001">
      <title>References</title>
      <ref id="humu22633-bib-0001">
        <mixed-citation publication-type="journal" id="humu22633-cit-0001">
<string-name>
<surname>Acquaviva</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Benoist</surname>
<given-names>JF</given-names>
</string-name>, <string-name>
<surname>Pereira</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Callebaut</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Koskas</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Porquet</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Elion</surname>
<given-names>J</given-names>
</string-name>. <year>2005</year>
<article-title>Molecular basis of methylmalonylâCoA mutase apoenzyme defect in 40 European patients affected by mut(o) and mutâforms of methylmalonic acidemia: identification of 29 novel mutations in the MUT gene</article-title>. <source>Hum Mutat</source>
<volume>25</volume>:<fpage>167</fpage>â<lpage>76</lpage>.<pub-id pub-id-type="pmid">15643616</pub-id></mixed-citation>
      </ref>
      <ref id="humu22633-bib-0002">
        <mixed-citation publication-type="journal" id="humu22633-cit-0002">
<string-name>
<surname>Arakawa</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Timasheff</surname>
<given-names>SN</given-names>
</string-name>. <year>1985</year>
<article-title>The stabilization of proteins by osmolytes</article-title>. <source>Biophys J</source>
<volume>47</volume>:<fpage>411</fpage>â<lpage>414</lpage>.<pub-id pub-id-type="pmid">3978211</pub-id></mixed-citation>
      </ref>
      <ref id="humu22633-bib-0003">
        <mixed-citation publication-type="journal" id="humu22633-cit-0003">
<string-name>
<surname>Ashkenazy</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Erez</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Martz</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Pupko</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>BenâTal</surname>
<given-names>N</given-names>
</string-name>. <year>2010</year>
<article-title>ConSurf 2010: calculating evolutionary conservation in sequence and structure of proteins and nucleic acids</article-title>. <source>Nucleic Acids Res</source>
<volume>38</volume>:<fpage>W529</fpage>â<lpage>W533</lpage>.<pub-id pub-id-type="pmid">20478830</pub-id></mixed-citation>
      </ref>
      <ref id="humu22633-bib-0004">
        <mixed-citation publication-type="journal" id="humu22633-cit-0004">
<string-name>
<surname>Banerjee</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Ragsdale</surname>
<given-names>SW</given-names>
</string-name>. <year>2003</year>
<article-title>The many faces of vitamin B12: catalysis by cobalaminâdependent enzymes</article-title>. <source>Annu Rev Biochem</source>
<volume>72</volume>:<fpage>209</fpage>â<lpage>247</lpage>.<pub-id pub-id-type="pmid">14527323</pub-id></mixed-citation>
      </ref>
      <ref id="humu22633-bib-0006">
        <mixed-citation publication-type="book" id="humu22633-cit-0006">
<string-name>
<surname>Baumgartner</surname>
<given-names>R</given-names>
</string-name>. <year>1983</year>
<chapter-title>Activity of the cobalaminâdependent methylmalonylâ<styled-content style="fixed-case">C</styled-content>o<styled-content style="fixed-case">A</styled-content> mutase</chapter-title> In: <person-group person-group-type="editor"><name><surname>Hall</surname><given-names>CA</given-names></name></person-group>, editor. <source>The cobalamins â volume 10 of methods in hematology</source>. <publisher-name>Churchill Livingstone</publisher-name>, <publisher-loc>London, UK</publisher-loc> p <fpage>181</fpage>â<lpage>193</lpage>.</mixed-citation>
      </ref>
      <ref id="humu22633-bib-0005">
        <mixed-citation publication-type="journal" id="humu22633-cit-0005">
<string-name>
<surname>Baumgartner</surname>
<given-names>MR</given-names>
</string-name>, <string-name>
<surname>Almashanu</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Suormala</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Obie</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Cole</surname>
<given-names>RN</given-names>
</string-name>, <string-name>
<surname>Packman</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Baumgartner</surname>
<given-names>ER</given-names>
</string-name>, <string-name>
<surname>Valle</surname>
<given-names>D</given-names>
</string-name>. <year>2001</year>
<article-title>The molecular basis of human 3âmethylcrotonylâ<styled-content style="fixed-case">C</styled-content>o<styled-content style="fixed-case">A</styled-content> carboxylase deficiency</article-title>. <source>J Clin Invest</source>
<volume>107</volume>:<fpage>495</fpage>â<lpage>504</lpage>.<pub-id pub-id-type="pmid">11181649</pub-id></mixed-citation>
      </ref>
      <ref id="humu22633-bib-0007">
        <mixed-citation publication-type="journal" id="humu22633-cit-0007">
<string-name>
<surname>Boyd</surname>
<given-names>RE</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Rybczynski</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Benjamin</surname>
<given-names>ER</given-names>
</string-name>, <string-name>
<surname>Khanna</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Wustman</surname>
<given-names>BA</given-names>
</string-name>, <string-name>
<surname>Valenzano</surname>
<given-names>KJ</given-names>
</string-name>. <year>2013</year>
<article-title>Pharmacological chaperones as therapeutics for lysosomal storage diseases</article-title>. <source>J Med Chem</source>
<volume>56</volume>:<fpage>2705</fpage>â<lpage>2725</lpage>.<pub-id pub-id-type="pmid">23363020</pub-id></mixed-citation>
      </ref>
      <ref id="humu22633-bib-0008">
        <mixed-citation publication-type="journal" id="humu22633-cit-0008">
<string-name>
<surname>Causey</surname>
<given-names>AG</given-names>
</string-name>, <string-name>
<surname>Bartlett</surname>
<given-names>K</given-names>
</string-name>. <year>1984</year>
<article-title>A radioâ<styled-content style="fixed-case">HPLC</styled-content> assay for the measurement of methylmalonylâ<styled-content style="fixed-case">C</styled-content>o<styled-content style="fixed-case">A</styled-content> mutase</article-title>. <source>Clin Chim Acta</source>
<volume>139</volume>:<fpage>179</fpage>â<lpage>186</lpage>.<pub-id pub-id-type="pmid">6145531</pub-id></mixed-citation>
      </ref>
      <ref id="humu22633-bib-0009">
        <mixed-citation publication-type="journal" id="humu22633-cit-0009">
<string-name>
<surname>Coelho</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Suormala</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Stucki</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>LernerâEllis</surname>
<given-names>JP</given-names>
</string-name>, <string-name>
<surname>Rosenblatt</surname>
<given-names>DS</given-names>
</string-name>, <string-name>
<surname>Newbold</surname>
<given-names>RF</given-names>
</string-name>, <string-name>
<surname>Baumgartner</surname>
<given-names>MR</given-names>
</string-name>, <string-name>
<surname>Fowler</surname>
<given-names>B</given-names>
</string-name>. <year>2008</year>
<article-title>Gene identification for the cbl<styled-content style="fixed-case">D</styled-content> defect of vitamin B12 metabolism</article-title>. <source>N Engl J Med</source>
<volume>358</volume>:<fpage>1454</fpage>â<lpage>1464</lpage>.<pub-id pub-id-type="pmid">18385497</pub-id></mixed-citation>
      </ref>
      <ref id="humu22633-bib-0010">
        <mixed-citation publication-type="journal" id="humu22633-cit-0010">
<string-name>
<surname>Cosson</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Benoist</surname>
<given-names>JF</given-names>
</string-name>, <string-name>
<surname>Touati</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Dechaux</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Royer</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Grandin</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Jais</surname>
<given-names>JP</given-names>
</string-name>, <string-name>
<surname>Boddaert</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Barbier</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Desguerre</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Campeau</surname>
<given-names>PM</given-names>
</string-name>, <string-name>
<surname>Rabier</surname>
<given-names>D</given-names>
</string-name> et al. <year>2009</year>
<article-title>Longâterm outcome in methylmalonic aciduria: a series of 30 <styled-content style="fixed-case">F</styled-content>rench patients</article-title>. <source>Mol Genet Metab</source>
<volume>97</volume>:<fpage>172</fpage>â<lpage>178</lpage>.<pub-id pub-id-type="pmid">19375370</pub-id></mixed-citation>
      </ref>
      <ref id="humu22633-bib-0011">
        <mixed-citation publication-type="journal" id="humu22633-cit-0011">
<string-name>
<surname>Crane</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Ledley</surname>
<given-names>FD</given-names>
</string-name>. <year>1994</year>
<article-title>Clustering of mutations in methylmalonyl <styled-content style="fixed-case">C</styled-content>o<styled-content style="fixed-case">A</styled-content> mutase associated with mutâmethylmalonic acidemia</article-title>. <source>Am J Hum Genet</source>
<volume>55</volume>:<fpage>42</fpage>â<lpage>50</lpage>.<pub-id pub-id-type="pmid">7912889</pub-id></mixed-citation>
      </ref>
      <ref id="humu22633-bib-0012">
        <mixed-citation publication-type="journal" id="humu22633-cit-0012">
<string-name>
<surname>Dundar</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Ozgul</surname>
<given-names>RK</given-names>
</string-name>, <string-name>
<surname>GuzelâOzanturk</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Dursun</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Sivri</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Aliefendioglu</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Coskun</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Tokatli</surname>
<given-names>A</given-names>
</string-name>. <year>2012</year>
<article-title>Microarray based mutational analysis of patients with methylmalonic acidemia: identification of 10 novel mutations</article-title>. <source>Mol Genet Metab</source>
<volume>106</volume>:<fpage>419</fpage>â<lpage>423</lpage>.<pub-id pub-id-type="pmid">22727635</pub-id></mixed-citation>
      </ref>
      <ref id="humu22633-bib-0013">
        <mixed-citation publication-type="journal" id="humu22633-cit-0013">
<string-name>
<surname>Fenton</surname>
<given-names>WA</given-names>
</string-name>, <string-name>
<surname>Hack</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Willard</surname>
<given-names>HF</given-names>
</string-name>, <string-name>
<surname>Gertler</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Rosenberg</surname>
<given-names>LE</given-names>
</string-name>. <year>1982</year>
<article-title>Purification and properties of methylmalonyl coenzyme <styled-content style="fixed-case">A</styled-content> mutase from human liver</article-title>. <source>Arch Biochem Biophys</source>
<volume>214</volume>:<fpage>815</fpage>â<lpage>823</lpage>.<pub-id pub-id-type="pmid">6124211</pub-id></mixed-citation>
      </ref>
      <ref id="humu22633-bib-0014">
        <mixed-citation publication-type="journal" id="humu22633-cit-0014">
<string-name>
<surname>Fowler</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Leonard</surname>
<given-names>JV</given-names>
</string-name>, <string-name>
<surname>Baumgartner</surname>
<given-names>MR</given-names>
</string-name>. <year>2008</year>
<article-title>Causes of and diagnostic approach to methylmalonic acidurias</article-title>. <source>J Inherit Metab Dis</source>
<volume>31</volume>:<fpage>350</fpage>â<lpage>360</lpage>.<pub-id pub-id-type="pmid">18563633</pub-id></mixed-citation>
      </ref>
      <ref id="humu22633-bib-0015">
        <mixed-citation publication-type="journal" id="humu22633-cit-0015">
<string-name>
<surname>Froese</surname>
<given-names>DS</given-names>
</string-name>, <string-name>
<surname>Gravel</surname>
<given-names>RA</given-names>
</string-name>. <year>2010</year>
<article-title>Genetic disorders of vitamin B metabolism: eight complementation groupsâeight genes</article-title>. <source>Expert Rev Mol Med</source>
<volume>12</volume>:<fpage>e37</fpage>.<pub-id pub-id-type="pmid">21114891</pub-id></mixed-citation>
      </ref>
      <ref id="humu22633-bib-0016">
        <mixed-citation publication-type="journal" id="humu22633-cit-0016">
<string-name>
<surname>Froese</surname>
<given-names>DS</given-names>
</string-name>, <string-name>
<surname>Healy</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>McDonald</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kochan</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Oppermann</surname>
<given-names>U</given-names>
</string-name>, <string-name>
<surname>Niesen</surname>
<given-names>FH</given-names>
</string-name>, <string-name>
<surname>Gravel</surname>
<given-names>RA</given-names>
</string-name>. <year>2010a</year>
<article-title>Thermolability of mutant <styled-content style="fixed-case">MMACHC</styled-content> protein in the vitamin B12âresponsive cbl<styled-content style="fixed-case">C</styled-content> disorder</article-title>. <source>Mol Genet Metab</source>
<volume>100</volume>:<fpage>29</fpage>â<lpage>36</lpage>.<pub-id pub-id-type="pmid">20219402</pub-id></mixed-citation>
      </ref>
      <ref id="humu22633-bib-0017">
        <mixed-citation publication-type="journal" id="humu22633-cit-0017">
<string-name>
<surname>Froese</surname>
<given-names>DS</given-names>
</string-name>, <string-name>
<surname>Kochan</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Muniz</surname>
<given-names>JR</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Gileadi</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Ugochukwu</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Krysztofinska</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Gravel</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>Oppermann</surname>
<given-names>U</given-names>
</string-name>, <string-name>
<surname>Yue</surname>
<given-names>WW</given-names>
</string-name>. <year>2010b</year>
<article-title>Structures of the human <styled-content style="fixed-case">GTP</styled-content>ase <styled-content style="fixed-case">MMAA</styled-content> and vitamin <styled-content style="fixed-case">B</styled-content>12âdependent methylmalonylâ<styled-content style="fixed-case">C</styled-content>o<styled-content style="fixed-case">A</styled-content> mutase and insight into their complex formation</article-title>. <source>J Biol Chem</source>
<volume>285</volume>:<fpage>38204</fpage>â<lpage>38213</lpage>.<pub-id pub-id-type="pmid">20876572</pub-id></mixed-citation>
      </ref>
      <ref id="humu22633-bib-0018">
        <mixed-citation publication-type="journal" id="humu22633-cit-0018">
<string-name>
<surname>Gomes</surname>
<given-names>CM</given-names>
</string-name>. <year>2012</year>
<article-title>Protein misfolding in disease and small molecule therapies</article-title>. <source>Curr Top Med Chem</source>
<volume>12</volume>:<fpage>2460</fpage>â<lpage>2469</lpage>.<pub-id pub-id-type="pmid">23339300</pub-id></mixed-citation>
      </ref>
      <ref id="humu22633-bib-0019">
        <mixed-citation publication-type="journal" id="humu22633-cit-0019">
<string-name>
<surname>Gravel</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>Mahoney</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Ruddle</surname>
<given-names>FH</given-names>
</string-name>, <string-name>
<surname>Rosenberg</surname>
<given-names>LE</given-names>
</string-name>. <year>1975</year>
<article-title>Genetic complementation in heterokaryons of human fibroblasts defective in cobalamin metabolism</article-title>. <source>Proc Natl Acad Sci USA</source>
<volume>72</volume>:<fpage>3181</fpage>â<lpage>3185</lpage>.<pub-id pub-id-type="pmid">1059104</pub-id></mixed-citation>
      </ref>
      <ref id="humu22633-bib-0020">
        <mixed-citation publication-type="journal" id="humu22633-cit-0020">
<string-name>
<surname>Gregersen</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Bross</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Vang</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Christensen</surname>
<given-names>JH</given-names>
</string-name>. <year>2006</year>
<article-title>Protein misfolding and human disease</article-title>. <source>Annu Rev Genomics Hum Genet</source>
<volume>7</volume>:<fpage>103</fpage>â<lpage>124</lpage>.<pub-id pub-id-type="pmid">16722804</pub-id></mixed-citation>
      </ref>
      <ref id="humu22633-bib-0021">
        <mixed-citation publication-type="journal" id="humu22633-cit-0021">
<string-name>
<surname>Horster</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Baumgartner</surname>
<given-names>MR</given-names>
</string-name>, <string-name>
<surname>Viardot</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Suormala</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Burgard</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Fowler</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Hoffmann</surname>
<given-names>GF</given-names>
</string-name>, <string-name>
<surname>Garbade</surname>
<given-names>SF</given-names>
</string-name>, <string-name>
<surname>Kolker</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Baumgartner</surname>
<given-names>ER</given-names>
</string-name>. <year>2007</year>
<article-title>Longâterm outcome in methylmalonic acidurias is influenced by the underlying defect (mut0, mutâ, cblA, cbl<styled-content style="fixed-case">B</styled-content>)</article-title>. <source>Pediatr Res</source>
<volume>62</volume>:<fpage>225</fpage>â<lpage>230</lpage>.<pub-id pub-id-type="pmid">17597648</pub-id></mixed-citation>
      </ref>
      <ref id="humu22633-bib-0022">
        <mixed-citation publication-type="journal" id="humu22633-cit-0022">
<string-name>
<surname>Janata</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Kogekar</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Fenton</surname>
<given-names>WA</given-names>
</string-name>. <year>1997</year>
<article-title>Expression and kinetic characterization of methylmalonylâ<styled-content style="fixed-case">C</styled-content>o<styled-content style="fixed-case">A</styled-content> mutase from patients with the mutâ phenotype: evidence for naturally occurring interallelic complementation</article-title>. <source>Hum Mol Genet</source>
<volume>6</volume>:<fpage>1457</fpage>â<lpage>1464</lpage>.<pub-id pub-id-type="pmid">9285782</pub-id></mixed-citation>
      </ref>
      <ref id="humu22633-bib-0023">
        <mixed-citation publication-type="journal" id="humu22633-cit-0023">
<string-name>
<surname>Krissinel</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Henrick</surname>
<given-names>K</given-names>
</string-name>. <year>2007</year>
<article-title>Inference of macromolecular assemblies from crystalline state</article-title>. <source>J Mol Biol</source>
<volume>372</volume>:<fpage>774</fpage>â<lpage>797</lpage>.<pub-id pub-id-type="pmid">17681537</pub-id></mixed-citation>
      </ref>
      <ref id="humu22633-bib-0024">
        <mixed-citation publication-type="journal" id="humu22633-cit-0024">
<string-name>
<surname>Kumar</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Henikoff</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Ng</surname>
<given-names>PC</given-names>
</string-name>. <year>2009</year>
<article-title>Predicting the effects of coding nonâsynonymous variants on protein function using the <styled-content style="fixed-case">SIFT</styled-content> algorithm</article-title>. <source>Nat Protoc</source>
<volume>4</volume>:<fpage>1073</fpage>â<lpage>1082</lpage>.<pub-id pub-id-type="pmid">19561590</pub-id></mixed-citation>
      </ref>
      <ref id="humu22633-bib-0025">
        <mixed-citation publication-type="journal" id="humu22633-cit-0025">
<string-name>
<surname>Leandro</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Leandro</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Flatmark</surname>
<given-names>T</given-names>
</string-name>. <year>2011</year>
<article-title>Heterotetrameric forms of human phenylalanine hydroxylase: coâexpression of wildâtype and mutant forms in a bicistronic system</article-title>. <source>Biochim Biophys Acta</source>
<volume>1812</volume>:<fpage>602</fpage>â<lpage>612</lpage>.<pub-id pub-id-type="pmid">21315150</pub-id></mixed-citation>
      </ref>
      <ref id="humu22633-bib-0026">
        <mixed-citation publication-type="journal" id="humu22633-cit-0026">
<string-name>
<surname>Ledley</surname>
<given-names>FD</given-names>
</string-name>, <string-name>
<surname>Lumetta</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Nguyen</surname>
<given-names>PN</given-names>
</string-name>, <string-name>
<surname>Kolhouse</surname>
<given-names>JF</given-names>
</string-name>, <string-name>
<surname>Allen</surname>
<given-names>RH</given-names>
</string-name>. <year>1988a</year>
<article-title>Molecular cloning of <styled-content style="fixed-case">L</styled-content>âmethylmalonylâ<styled-content style="fixed-case">C</styled-content>o<styled-content style="fixed-case">A</styled-content> mutase: gene transfer and analysis of mut cell lines</article-title>. <source>Proc Natl Acad Sci USA</source>
<volume>85</volume>:<fpage>3518</fpage>â<lpage>3521</lpage>.<pub-id pub-id-type="pmid">2453061</pub-id></mixed-citation>
      </ref>
      <ref id="humu22633-bib-0027">
        <mixed-citation publication-type="journal" id="humu22633-cit-0027">
<string-name>
<surname>Ledley</surname>
<given-names>FD</given-names>
</string-name>, <string-name>
<surname>Lumetta</surname>
<given-names>MR</given-names>
</string-name>, <string-name>
<surname>Zoghbi</surname>
<given-names>HY</given-names>
</string-name>, <string-name>
<surname>Vantuinen</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Ledbetter</surname>
<given-names>SA</given-names>
</string-name>, <string-name>
<surname>Ledbetter</surname>
<given-names>DH</given-names>
</string-name>. <year>1988b</year>
<article-title>Mapping of human methylmalonyl <styled-content style="fixed-case">C</styled-content>o<styled-content style="fixed-case">A</styled-content> mutase (<styled-content style="fixed-case">M</styled-content>ut) locus on chromosomeâ6</article-title>. <source>Am J Hum Genet</source>
<volume>42</volume>:<fpage>839</fpage>â<lpage>846</lpage>.<pub-id pub-id-type="pmid">2897160</pub-id></mixed-citation>
      </ref>
      <ref id="humu22633-bib-0028">
        <mixed-citation publication-type="journal" id="humu22633-cit-0028">
<string-name>
<surname>Ledley</surname>
<given-names>FD</given-names>
</string-name>, <string-name>
<surname>Rosenblatt</surname>
<given-names>DS</given-names>
</string-name>. <year>1997</year>
<article-title>Mutations in mut methylmalonic acidemia: clinical and enzymatic correlations</article-title>. <source>Hum Mutat</source>
<volume>9</volume>:<fpage>1</fpage>â<lpage>6</lpage>.<pub-id pub-id-type="pmid">8990001</pub-id></mixed-citation>
      </ref>
      <ref id="humu22633-bib-0029">
        <mixed-citation publication-type="journal" id="humu22633-cit-0029">
<string-name>
<surname>Leinekugel</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Michel</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Conzelmann</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Sandhoff</surname>
<given-names>K</given-names>
</string-name>. <year>1992</year>
<article-title>Quantitative correlation between the residual activity of betaâhexosaminidaseâa and arylsulfataseâa and the severity of the resulting lysosomal storage disease</article-title>. <source>Hum Genet</source>
<volume>88</volume>:<fpage>513</fpage>â<lpage>523</lpage>.<pub-id pub-id-type="pmid">1348043</pub-id></mixed-citation>
      </ref>
      <ref id="humu22633-bib-0030">
        <mixed-citation publication-type="journal" id="humu22633-cit-0030">
<string-name>
<surname>Lempp</surname>
<given-names>TJ</given-names>
</string-name>, <string-name>
<surname>Suormala</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Siegenthaler</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Baumgartner</surname>
<given-names>ER</given-names>
</string-name>, <string-name>
<surname>Fowler</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Steinmann</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Baumgartner</surname>
<given-names>MR</given-names>
</string-name>. <year>2007</year>
<article-title>Mutation and biochemical analysis of 19 probands with mut0 and 13 with mutâ methylmalonic aciduria: identification of seven novel mutations</article-title>. <source>Mol Genet Metab</source>
<volume>90</volume>:<fpage>284</fpage>â<lpage>290</lpage>.<pub-id pub-id-type="pmid">17113806</pub-id></mixed-citation>
      </ref>
      <ref id="humu22633-bib-0031">
        <mixed-citation publication-type="journal" id="humu22633-cit-0031">
<string-name>
<surname>Litzkas</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Jha</surname>
<given-names>KK</given-names>
</string-name>, <string-name>
<surname>Ozer</surname>
<given-names>HL</given-names>
</string-name>. <year>1984</year>
<article-title>Efficient transfer of cloned <styled-content style="fixed-case">DNA</styled-content> into human diploid cells: protoplast fusion in suspension</article-title>. <source>Mol Cell Biol</source>
<volume>4</volume>:<fpage>2549</fpage>â<lpage>2552</lpage>.<pub-id pub-id-type="pmid">6096698</pub-id></mixed-citation>
      </ref>
      <ref id="humu22633-bib-0032">
        <mixed-citation publication-type="journal" id="humu22633-cit-0032">
<string-name>
<surname>Loferer</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Webb</surname>
<given-names>BM</given-names>
</string-name>, <string-name>
<surname>Grant</surname>
<given-names>GH</given-names>
</string-name>, <string-name>
<surname>Liedl</surname>
<given-names>KR</given-names>
</string-name>. <year>2003</year>
<article-title>Energetic and stereochemical effects of the protein environment on substrate: a theoretical study of methylmalonylâ<styled-content style="fixed-case">C</styled-content>o<styled-content style="fixed-case">A</styled-content> mutase</article-title>. <source>J Am Chem Soc</source>
<volume>125</volume>:<fpage>1072</fpage>â<lpage>1078</lpage>.<pub-id pub-id-type="pmid">12537507</pub-id></mixed-citation>
      </ref>
      <ref id="humu22633-bib-0033">
        <mixed-citation publication-type="journal" id="humu22633-cit-0033">
<string-name>
<surname>Majtan</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Carpenter</surname>
<given-names>JF</given-names>
</string-name>, <string-name>
<surname>Kraus</surname>
<given-names>JP</given-names>
</string-name>. <year>2010</year>
<article-title>Rescue of cystathionine betaâsynthase (<styled-content style="fixed-case">CBS</styled-content>) mutants with chemical chaperones: purification and characterization of eight <styled-content style="fixed-case">CBS</styled-content> mutant enzymes</article-title>. <source>J Biol Chem</source>
<volume>285</volume>:<fpage>15866</fpage>â<lpage>15873</lpage>.<pub-id pub-id-type="pmid">20308073</pub-id></mixed-citation>
      </ref>
      <ref id="humu22633-bib-0034">
        <mixed-citation publication-type="journal" id="humu22633-cit-0034">
<string-name>
<surname>Mancia</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Keep</surname>
<given-names>NH</given-names>
</string-name>, <string-name>
<surname>Nakagawa</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Leadlay</surname>
<given-names>PF</given-names>
</string-name>, <string-name>
<surname>McSweeney</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Rasmussen</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Bosecke</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Diat</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Evans</surname>
<given-names>PR</given-names>
</string-name>. <year>1996</year>
<article-title>How coenzyme <styled-content style="fixed-case">B</styled-content>â12 radicals are generated: the crystal structure of methylmalonylâcoenzyme <styled-content style="fixed-case">A</styled-content> mutase at 2 angstrom resolution</article-title>. <source>Structure</source>
<volume>4</volume>:<fpage>339</fpage>â<lpage>350</lpage>.<pub-id pub-id-type="pmid">8805541</pub-id></mixed-citation>
      </ref>
      <ref id="humu22633-bib-0035">
        <mixed-citation publication-type="journal" id="humu22633-cit-0035">
<string-name>
<surname>Matsui</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Mahoney</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Rosenberg</surname>
<given-names>LE</given-names>
</string-name>. <year>1983</year>
<article-title>The natural history of the inherited methylmalonic acidemias</article-title>. <source>N Engl J Med</source>
<volume>308</volume>:<fpage>857</fpage>â<lpage>861</lpage>.<pub-id pub-id-type="pmid">6132336</pub-id></mixed-citation>
      </ref>
      <ref id="humu22633-bib-0036">
        <mixed-citation publication-type="journal" id="humu22633-cit-0036">
<string-name>
<surname>Mitchell</surname>
<given-names>JJ</given-names>
</string-name>, <string-name>
<surname>Trakadis</surname>
<given-names>YJ</given-names>
</string-name>, <string-name>
<surname>Scriver</surname>
<given-names>CR</given-names>
</string-name>. <year>2011</year>
<article-title>Phenylalanine hydroxylase deficiency</article-title>. <source>Genet Med</source>
<volume>13</volume>:<fpage>697</fpage>â<lpage>707</lpage>.<pub-id pub-id-type="pmid">21555948</pub-id></mixed-citation>
      </ref>
      <ref id="humu22633-bib-0037">
        <mixed-citation publication-type="journal" id="humu22633-cit-0037">
<string-name>
<surname>Morrow</surname>
<given-names>G</given-names>, <suffix>3rd</suffix>
</string-name>, <string-name>
<surname>Revsin</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Clark</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Lebowitz</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Whelan</surname>
<given-names>DT</given-names>
</string-name>. <year>1978</year>
<article-title>A new variant of methylmalonic acidemiaâdefective coenzymeâapoenzyme binding in cultured fibroblasts</article-title>. <source>Clin Chim Acta</source>
<volume>85</volume>:<fpage>67</fpage>â<lpage>72</lpage>.<pub-id pub-id-type="pmid">25730</pub-id></mixed-citation>
      </ref>
      <ref id="humu22633-bib-0038">
        <mixed-citation publication-type="journal" id="humu22633-cit-0038">
<string-name>
<surname>Nascimento</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Leandro</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Tavares de Almeida</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Leandro</surname>
<given-names>P</given-names>
</string-name>. <year>2008</year>
<article-title>Modulation of the activity of newly synthesized human phenylalanine hydroxylase mutant proteins by lowâmolecularâweight compounds</article-title>. <source>Protein J</source>
<volume>27</volume>:<fpage>392</fpage>â<lpage>400</lpage>.<pub-id pub-id-type="pmid">18769885</pub-id></mixed-citation>
      </ref>
      <ref id="humu22633-bib-0039">
        <mixed-citation publication-type="journal" id="humu22633-cit-0039">
<string-name>
<surname>Niesen</surname>
<given-names>FH</given-names>
</string-name>, <string-name>
<surname>Berglund</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Vedadi</surname>
<given-names>M</given-names>
</string-name>. <year>2007</year>
<article-title>The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability</article-title>. <source>Nat Protoc</source>
<volume>2</volume>:<fpage>2212</fpage>â<lpage>2221</lpage>.<pub-id pub-id-type="pmid">17853878</pub-id></mixed-citation>
      </ref>
      <ref id="humu22633-bib-0040">
        <mixed-citation publication-type="journal" id="humu22633-cit-0040">
<string-name>
<surname>Pekkala</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Martinez</surname>
<given-names>AI</given-names>
</string-name>, <string-name>
<surname>Barcelona</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Yefimenko</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Finckh</surname>
<given-names>U</given-names>
</string-name>, <string-name>
<surname>Rubio</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Cervera</surname>
<given-names>J</given-names>
</string-name>. <year>2010</year>
<article-title>Understanding carbamoylâphosphate synthetase I (<styled-content style="fixed-case">CPS</styled-content>1) deficiency by using expression studies and structureâbased analysis</article-title>. <source>Hum Mutat</source>
<volume>31</volume>:<fpage>801</fpage>â<lpage>808</lpage>.<pub-id pub-id-type="pmid">20578160</pub-id></mixed-citation>
      </ref>
      <ref id="humu22633-bib-0041">
        <mixed-citation publication-type="journal" id="humu22633-cit-0041">
<string-name>
<surname>Pey</surname>
<given-names>AL</given-names>
</string-name>, <string-name>
<surname>Stricher</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Serrano</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Martinez</surname>
<given-names>A</given-names>
</string-name>. <year>2007</year>
<article-title>Predicted effects of missense mutations on nativeâstate stability account for phenotypic outcome in phenylketonuria, a paradigm of misfolding diseases</article-title>. <source>Am J Hum Genet</source>
<volume>81</volume>:<fpage>1006</fpage>â<lpage>1024</lpage>.<pub-id pub-id-type="pmid">17924342</pub-id></mixed-citation>
      </ref>
      <ref id="humu22633-bib-0042">
        <mixed-citation publication-type="journal" id="humu22633-cit-0042">
<string-name>
<surname>Pey</surname>
<given-names>AL</given-names>
</string-name>, <string-name>
<surname>Ying</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Cremades</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>VelazquezâCampoy</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Scherer</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Thony</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Sancho</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Martinez</surname>
<given-names>A</given-names>
</string-name>. <year>2008</year>
<article-title>Identification of pharmacological chaperones as potential therapeutic agents to treat phenylketonuria</article-title>. <source>J Clin Invest</source>
<volume>118</volume>:<fpage>2858</fpage>â<lpage>2867</lpage>.<pub-id pub-id-type="pmid">18596920</pub-id></mixed-citation>
      </ref>
      <ref id="humu22633-bib-0043">
        <mixed-citation publication-type="journal" id="humu22633-cit-0043">
<string-name>
<surname>Shchelochkov</surname>
<given-names>OA</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>FY</given-names>
</string-name>, <string-name>
<surname>Geraghty</surname>
<given-names>MT</given-names>
</string-name>, <string-name>
<surname>Gallagher</surname>
<given-names>RC</given-names>
</string-name>, <string-name>
<surname>Van Hove</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>LichterâKonecki</surname>
<given-names>U</given-names>
</string-name>, <string-name>
<surname>Fernhoff</surname>
<given-names>PM</given-names>
</string-name>, <string-name>
<surname>Copeland</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Reimschisel</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Cederbaum</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Chinault</surname>
<given-names>AC</given-names>
</string-name> et al. <year>2009</year>
<article-title>Highâfrequency detection of deletions and variable rearrangements at the ornithine transcarbamylase (<styled-content style="fixed-case">OTC</styled-content>) locus by oligonucleotide array <styled-content style="fixed-case">CGH</styled-content>
</article-title>. <source>Mol Genet Metab</source>
<volume>96</volume>:<fpage>97</fpage>â<lpage>105</lpage>.<pub-id pub-id-type="pmid">19138872</pub-id></mixed-citation>
      </ref>
      <ref id="humu22633-bib-0044">
        <mixed-citation publication-type="journal" id="humu22633-cit-0044">
<string-name>
<surname>Shi</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Sellers</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Moult</surname>
<given-names>J</given-names>
</string-name>. <year>2012</year>
<article-title>Protein stability and in vivo concentration of missense mutations in phenylalanine hydroxylase</article-title>. <source>Proteins</source>
<volume>80</volume>:<fpage>61</fpage>â<lpage>70</lpage>.<pub-id pub-id-type="pmid">21953985</pub-id></mixed-citation>
      </ref>
      <ref id="humu22633-bib-0045">
        <mixed-citation publication-type="journal" id="humu22633-cit-0045">
<string-name>
<surname>Suormala</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Baumgartner</surname>
<given-names>MR</given-names>
</string-name>, <string-name>
<surname>Coelho</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Zavadakova</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Kozich</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Koch</surname>
<given-names>HG</given-names>
</string-name>, <string-name>
<surname>Berghauser</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Wraith</surname>
<given-names>JE</given-names>
</string-name>, <string-name>
<surname>Burlina</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Sewell</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Herwig</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Fowler</surname>
<given-names>B</given-names>
</string-name>. <year>2004</year>
<article-title>The cbl<styled-content style="fixed-case">D</styled-content> defect causes either isolated or combined deficiency of methylcobalamin and adenosylcobalamin synthesis</article-title>. <source>J Biol Chem</source>
<volume>279</volume>:<fpage>42742</fpage>â<lpage>42749</lpage>.<pub-id pub-id-type="pmid">15292234</pub-id></mixed-citation>
      </ref>
      <ref id="humu22633-bib-0046">
        <mixed-citation publication-type="journal" id="humu22633-cit-0046">
<string-name>
<surname>Suzuki</surname>
<given-names>Y</given-names>
</string-name>. <year>2013</year>
<article-title>Chaperone therapy update: <styled-content style="fixed-case">F</styled-content>abry disease, <styled-content style="fixed-case">G</styled-content>(<styled-content style="fixed-case">M</styled-content>1)âgangliosidosis and <styled-content style="fixed-case">G</styled-content>aucher disease</article-title>. <source>Brain DevâJpn</source>
<volume>35</volume>:<fpage>515</fpage>â<lpage>523</lpage>.</mixed-citation>
      </ref>
      <ref id="humu22633-bib-0047">
        <mixed-citation publication-type="journal" id="humu22633-cit-0047">
<string-name>
<surname>Thompson</surname>
<given-names>GN</given-names>
</string-name>, <string-name>
<surname>Chalmers</surname>
<given-names>RA</given-names>
</string-name>. <year>1990</year>
<article-title>Increased urinary metabolite excretion during fasting in disorders of propionate metabolism</article-title>. <source>Pediatr Res</source>
<volume>27</volume>:<fpage>413</fpage>â<lpage>416</lpage>.<pub-id pub-id-type="pmid">2342832</pub-id></mixed-citation>
      </ref>
      <ref id="humu22633-bib-0048">
        <mixed-citation publication-type="journal" id="humu22633-cit-0048">
<string-name>
<surname>Valdar</surname>
<given-names>WS</given-names>
</string-name>. <year>2002</year>
<article-title>Scoring residue conservation</article-title>. <source>Proteins</source>
<volume>48</volume>:<fpage>227</fpage>â<lpage>241</lpage>.<pub-id pub-id-type="pmid">12112692</pub-id></mixed-citation>
      </ref>
      <ref id="humu22633-bib-0049">
        <mixed-citation publication-type="journal" id="humu22633-cit-0049">
<string-name>
<surname>Vedadi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Niesen</surname>
<given-names>FH</given-names>
</string-name>, <string-name>
<surname>AllaliâHassani</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Fedorov</surname>
<given-names>OY</given-names>
</string-name>, <string-name>
<surname>Finerty</surname>
<given-names>PJ</given-names>, <suffix>Jr.</suffix>
</string-name>, <string-name>
<surname>Wasney</surname>
<given-names>GA</given-names>
</string-name>, <string-name>
<surname>Yeung</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Arrowsmith</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Ball</surname>
<given-names>LJ</given-names>
</string-name>, <string-name>
<surname>Berglund</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Hui</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Marsden</surname>
<given-names>BD</given-names>
</string-name> et al. <year>2006</year>
<article-title>Chemical screening methods to identify ligands that promote protein stability, protein crystallization, and structure determination</article-title>. <source>Proc Natl Acad Sci USA</source>
<volume>103</volume>:<fpage>15835</fpage>â<lpage>15840</lpage>.<pub-id pub-id-type="pmid">17035505</pub-id></mixed-citation>
      </ref>
      <ref id="humu22633-bib-0050">
        <mixed-citation publication-type="journal" id="humu22633-cit-0050">
<string-name>
<surname>Wilcken</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Kilham</surname>
<given-names>HA</given-names>
</string-name>, <string-name>
<surname>Faull</surname>
<given-names>K</given-names>
</string-name>. <year>1977</year>
<article-title>Methylmalonic aciduria: a variant form of methylmalonyl coenzyme A apomutase deficiency</article-title>. <source>J Pediatr</source>
<volume>91</volume>:<fpage>428</fpage>â<lpage>430</lpage>.<pub-id pub-id-type="pmid">19569</pub-id></mixed-citation>
      </ref>
      <ref id="humu22633-bib-0051">
        <mixed-citation publication-type="journal" id="humu22633-cit-0051">
<string-name>
<surname>Wilkemeyer</surname>
<given-names>MF</given-names>
</string-name>, <string-name>
<surname>Crane</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Ledley</surname>
<given-names>FD</given-names>
</string-name>. <year>1991</year>
<article-title>Differential diagnosis of mut and cbl methylmalonic aciduria by <styled-content style="fixed-case">DNA</styled-content>âmediated gene transfer in primary fibroblasts</article-title>. <source>J Clin Invest</source>
<volume>87</volume>:<fpage>915</fpage>â<lpage>918</lpage>.<pub-id pub-id-type="pmid">1671869</pub-id></mixed-citation>
      </ref>
      <ref id="humu22633-bib-0052">
        <mixed-citation publication-type="journal" id="humu22633-cit-0052">
<string-name>
<surname>Willard</surname>
<given-names>HF</given-names>
</string-name>, <string-name>
<surname>Mellman</surname>
<given-names>IS</given-names>
</string-name>, <string-name>
<surname>Rosenberg</surname>
<given-names>LE</given-names>
</string-name>. <year>1978</year>
<article-title>Genetic complementation among inherited deficiencies of methylmalonylâ<styled-content style="fixed-case">C</styled-content>o<styled-content style="fixed-case">A</styled-content> mutase activity â evidence for a new class of human cobalamin mutant</article-title>. <source>Am J Hum Genet</source>
<volume>30</volume>:<fpage>1</fpage>â<lpage>13</lpage>.<pub-id pub-id-type="pmid">23678</pub-id></mixed-citation>
      </ref>
      <ref id="humu22633-bib-0053">
        <mixed-citation publication-type="journal" id="humu22633-cit-0053">
<string-name>
<surname>Willard</surname>
<given-names>HF</given-names>
</string-name>, <string-name>
<surname>Rosenberg</surname>
<given-names>LE</given-names>
</string-name>. <year>1980</year>
<article-title>Inherited methylmalonyl CoA mutase apoenzyme deficiency in human fibroblasts: evidence for allelic heterogeneity, genetic compounds, and codominant expression</article-title>. <source>J Clin Invest</source>
<volume>65</volume>:<fpage>690</fpage>â<lpage>698</lpage>.<pub-id pub-id-type="pmid">6101601</pub-id></mixed-citation>
      </ref>
      <ref id="humu22633-bib-0054">
        <mixed-citation publication-type="journal" id="humu22633-cit-0054">
<string-name>
<surname>Worgan</surname>
<given-names>LC</given-names>
</string-name>, <string-name>
<surname>Niles</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Tirone</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Hofmann</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Verner</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Sammak</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Kucic</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Lepage</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Rosenblatt</surname>
<given-names>DS</given-names>
</string-name>. <year>2006</year>
<article-title>Spectrum of mutations in mut methylmalonic acidemia and identification of a common Hispanic mutation and haplotype</article-title>. <source>Hum Mutat</source>
<volume>27</volume>:<fpage>31</fpage>â<lpage>43</lpage>.<pub-id pub-id-type="pmid">16281286</pub-id></mixed-citation>
      </ref>
      <ref id="humu22633-bib-0055">
        <mixed-citation publication-type="journal" id="humu22633-cit-0055">
<string-name>
<surname>Yue</surname>
<given-names>WW</given-names>
</string-name>, <string-name>
<surname>Froese</surname>
<given-names>DS</given-names>
</string-name>, <string-name>
<surname>Brennan</surname>
<given-names>PE</given-names>
</string-name>. <year>2014</year>
<article-title>The role of protein structural analysis in the next generation sequencing era</article-title>. <source>Top Curr Chem</source>
<volume>336</volume>:<fpage>67</fpage>â<lpage>98</lpage>.<pub-id pub-id-type="pmid">22610134</pub-id></mixed-citation>
      </ref>
      <ref id="humu22633-bib-0056">
        <mixed-citation publication-type="journal" id="humu22633-cit-0056">
<string-name>
<surname>Zurfluh</surname>
<given-names>MR</given-names>
</string-name>, <string-name>
<surname>Zschocke</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Lindner</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Feillet</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Chery</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Burlina</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Stevens</surname>
<given-names>RC</given-names>
</string-name>, <string-name>
<surname>Thony</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Blau</surname>
<given-names>N</given-names>
</string-name>. <year>2008</year>
<article-title>Molecular genetics of tetrahydrobiopterinâresponsive phenylalanine hydroxylase deficiency</article-title>. <source>Hum Mutat</source>
<volume>29</volume>:<fpage>167</fpage>â<lpage>175</lpage>.<pub-id pub-id-type="pmid">17935162</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record></GetRecord></OAI-PMH>